Sandbox:Hannan: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(474 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
'''Abbreviations'''


{{CMG}}; {{AE}} {{HMHJ}}
ACTH: Adrenocorticotropic hormone, ARR: Aldosterone-renin ratio, CAM: Cellular adhesion molecules, ERCP: Endoscopic retrograde cholangiopancreatography, ESR: Erythrocyte sedimentation rate, CT: Computerized tomography, Fluorescence in situ hybridization, FDG: Fluorodeoxyglucose, FSH: Follicle stimulating hormone, GI: Gastrointestinal, H&E stain: Hematoxylin and eosin stain, LCA: Leukocyte common antigen, LDH: Lactate dehydrogenase, LH: Luteinizing hormone, MEN: Multiple endocrine neoplasia, MRCP: Magnetic resonance cholangiopancreatography, MRI: Magnetic resonance imaging, N/A: Not applicable/Not available, N/L: Normal, PAS stain: Periodic acid–Schiff stain, PET: Position emission tomography, PGP: Protein gene product 9.5, TB: Tuberculosis, U/S: Ultrasound, ZF: Zona fasciculata, ZG: Zona granulosa, ZR: Zona reticularis.
 
==Overview==
{| class="wikitable"
{| class="wikitable"
|+
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Adrenal Cortex
! colspan="5" |Vascular Anomalies
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnosis
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptoms
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Signs
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Ultrasound
! style="background:#4479BA; color: #FFFFFF;" align="center" + |CT scan
! style="background:#4479BA; color: #FFFFFF;" align="center" + |FDG PET/CT
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MRI
|-
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Adrenal [[Adrenal adenoma|Adenoma]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Aldosterone]]<br><ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |pmc=5258164 |doi=10.1259/bjr.20151018 |url=}}</ref><ref name="pmid25958045">{{cite journal |vauthors=Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P |title=Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas |journal=Mol. Cell. Endocrinol. |volume=411 |issue= |pages=146–54 |date=August 2015 |pmid=25958045 |pmc=4474471 |doi=10.1016/j.mce.2015.04.022 |url=}}</ref><ref name="pmid20498828">{{cite journal |vauthors=Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD |title=Laboratory investigation of primary aldosteronism |journal=Clin Biochem Rev |volume=31 |issue=2 |pages=39–56 |date=May 2010 |pmid=20498828 |pmc=2874431 |doi= |url=}}</ref><ref name="pmid24605256">{{cite journal |vauthors=Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C |title=Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging |journal=J Clin Imaging Sci |volume=3 |issue= |pages=61 |date=2013 |pmid=24605256 |pmc=3935261 |doi=10.4103/2156-7514.124088 |url=}}</ref>
|
* [[Headache]]
* [[Vision]] problems
* [[Muscle]] [[cramps]]
* [[Muscle]] weakness & [[cramps]]
* [[Numbness]]
* Temporary [[paralysis]]
* [[Polyuria]] and [[polydipsia]]
|
* [[Hypertension]]
* [[Refractory hypertension]]
|
* [[Hypokalemia]]
* [[Alkalosis]]
* ↑ [[Plasma]] [[aldosterone]]
* ↓ [[Plasma]] [[Renin]]
* ↑ ARR
|
* Single or multiple [[nodules]]
* Encapsulated
* Abundant clear [[cytoplasm]]
* Uniforming [[nuclei]]
* [[Histopathology]] may resemble:
** [[Zona fasciculata|ZF]] (large, [[lipid]]-laden clear [[cells]])
** [[Zona fasciculata|ZG]] (small, compact [[cells]] with moderate amount of [[lipid]])
** [[Zona reticularis|ZR]] (lipid-sparse [[cytoplasm]])
|
* [[Fludrocortisone]] suppression testing (Gold standard)
* Oral [[Sodium]] loading
* [[Saline]] infusion testing
* [[Captopril]] test
* [[Adrenal venous sampling]]
* Posture test
* [[Genetic testing]]
* [[Immunohistochemical staining]]
*
|
* [[Adrenal]] [[mass]] or [[nodule]]
|
* [[nodule|Adrenal]] [[mass]] or nodule
* [[nodule|Unilateral or bilateral]] [[adrenal]] [[atrophy]]
* [[nodule|Hypodense]] [[mass]]
|
* Iso and low [[FDG]] uptake compared with [[liver]]
|
* Hyperintense on in-phase and hypointense on oppose-phase
|
* [[Glucocorticoid]]-Remediable [[Aldosteronism]] responds to [[glucocorticoids]]
* Higher [[cardiovascular]] and [[cerebrovascular]] [[morbidity]]
|-
|-
!Vascular Tumors
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cortisol]]<br><ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |pmc=5258164 |doi=10.1259/bjr.20151018 |url=}}</ref><ref name="pmid18493137">{{cite journal |vauthors=Stratakis CA |title=Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome) |journal=Endocr Dev |volume=13 |issue= |pages=117–32 |date=2008 |pmid=18493137 |pmc=3132884 |doi=10.1159/000134829 |url=}}</ref><ref name="pmid25871963">{{cite journal |vauthors=Zilbermint M, Stratakis CA |title=Protein kinase A defects and cortisol-producing adrenal tumors |journal=Curr Opin Endocrinol Diabetes Obes |volume=22 |issue=3 |pages=157–62 |date=June 2015 |pmid=25871963 |pmc=4560837 |doi=10.1097/MED.0000000000000149 |url=}}</ref><ref name="pmid29685132">{{cite journal |vauthors=Wei J, Li S, Liu Q, Zhu Y, Wu N, Tang Y, Li Q, Ren K, Zhang Q, Yu Y, An Z, Chen J, Li J |title=ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures |journal=BMC Endocr Disord |volume=18 |issue=1 |pages=22 |date=April 2018 |pmid=29685132 |pmc=5913873 |doi=10.1186/s12902-018-0250-6 |url=}}</ref>
! colspan="4" |Vascular Malformations
|
* [[Weight]] gain
* [[Growth retardation]]
* [[Headache]]
* [[Amenorrhea]]
* [[Virilization]] (rare)
* [[Acne]]
* Violaceous [[striae]]
* [[Acanthosis nigricans]]
* [[Sleep]] disruption
* [[Mental]] changes
* [[Muscular]] weakneness
|
* [[Hypertension]]
* [[Hirsutism]]
* [[Hypogonadism]]
* [[Growth retardation]]
* [[Facial]] plethora
* [[Acne]]
* [[Striae]]
* [[Bruising]]
* [[Acanthosis nigricans]]
* [[Mental]] changes
* [[Muscular]] weakneness
|
* ↑ [[Plasma]] [[cortisol]]
* ↑ 24 Hour [[urinary]] [[cortisol]]
* ↓ or inappropriately normal [[plasma]] [[ACTH]]
* ↑ [[Blood]] [[glucose]]
|
* Yellow [[fat]]
* Brown [[discoloration]]
* Large [[cells]] with increased [[lipid]] contetnt (''[[zona fasciculata]])''
* May contain [[pigment]] ([[lipofuscin]])
* Adjacent [[Atrophy|atrophied]] [[cells]]
* [[Hemorrhage]] and [[calcification]] (Pre-[[malignant]] [[lesions]])
|
* Diurnal [[plasma]] [[cortisol]] variation
* Low dose and high dose [[dexamethasone suppression test]]
* [[Dexamethasone]]-[[CRH]] test
* Adrenal venous sampling
* [[Genetic testing]]
* [[Immunohistochemical staining]]
* [[Dual energy X-ray absorptiometry|Dual-energy X-ray absorptiometry]]
|
* [[Adrenal]] [[mass]] or [[nodule]]
* ↑ [[Fat]]
|
* [[Adrenal]] [[mass]] or [[nodule]]
* Unilateral or bilateral [[adrenal]] [[atrophy]]
* ↑ [[Fat]]
* Hypodense [[mass]]
|
* Iso and low [[FDG]] uptake compared with [[liver]]
|
* Hyperintense on in-phase and hypointense on oppose-phase
|
* Associated with [[Carney complex]]
* Associated with [[Multiple endocrine neoplasia type 1|MEN-1]]
* [[Plasma]] levels of [[cortisol]] and [[ACTH]] may show false positive and false negative results due to normal diurnal [[hormonal]] variation
|-
|-
| rowspan="2" |Benign
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Androgens]]<br><ref name="pmid24605256">{{cite journal |vauthors=Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C |title=Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging |journal=J Clin Imaging Sci |volume=3 |issue= |pages=61 |date=2013 |pmid=24605256 |pmc=3935261 |doi=10.4103/2156-7514.124088 |url=}}</ref><ref name="pmid16278716">{{cite journal |vauthors=Arnold DT, Reed JB, Burt K |title=Evaluation and management of the incidental adrenal mass |journal=Proc (Bayl Univ Med Cent) |volume=16 |issue=1 |pages=7–12 |date=January 2003 |pmid=16278716 |pmc=1200803 |doi= |url=}}</ref><ref name="pmid23819074">{{cite journal |vauthors=Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J |title=Pure androgen-secreting adrenal adenoma associated with resistant hypertension |journal=Case Rep Endocrinol |volume=2013 |issue= |pages=356086 |date=2013 |pmid=23819074 |pmc=3681270 |doi=10.1155/2013/356086 |url=}}</ref><ref name="pmid30674304">{{cite journal |vauthors=Zhou WB, Chen N, Li CJ |title=A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman |journal=BMC Endocr Disord |volume=19 |issue=1 |pages=14 |date=January 2019 |pmid=30674304 |pmc=6343319 |doi=10.1186/s12902-019-0342-y |url=}}</ref>
|
* [[Hirsutism]]
* [[Virilization]]
* [[Amenorrhea]]
* [[Precocious puberty]]
* [[Testicular]] [[atrophy]] & diminished [[libido]] ([[male]])
|
* [[Clitorimegaly]]
* [[Male]] pattern [[baldness]]
* [[Resistant hypertension]]
* [[Gynecomastia]]
|
* ↑ [[Serum]] [[testosterone]]
* ↑ [[Serum]] [[androstenedione]]
* ↑ [[Serum]] [[dehydroepiandrosterone sulfate]] ([[DHEA-S]])
* ↑ [[Urine]] 17-ketosteroids
* ↑ [[Plasma]] and [[urine]] [[estrogens]]


Locally aggressive or  
*
|
* Pale tan to brown
* Pseudocapsule or the [[fibrous]] [[capsule]]
* Nesting, alveolar, cords, [[trabeculae]]
* [[Eosinophilic]] [[cytoplasm]]
* May see clear, vacuolated [[cytoplasm]]


Borderline
*
 
|
Malignant
* [[FSH]], [[LH]], [[prolactin]] levels
|Simple
* [[Cortisol]] levels
|Combined°
* [[FDG]] [[PET]]/[[CT]]
|of major named vessels
* [[Pelvic]] [[Ultrasound]]
|associated with other anomalies
* [[Adrenal Venous sampling]]
|
* Well-defined
* Solid [[mass]]
|
* Homogeneous enhancement ([[CT]] [[contrast]])
|
* N/A
|
* Hyperintense on in-phase and hypointense on oppose-phase
|
* Extremely rare
* Most [[androgen]] secreting [[adenomas]] are mixed [[tumors]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Non-functional<br><ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |doi=10.1259/bjr.20151018 |url=}}</ref><ref name="pmid27479926">{{cite journal |vauthors=Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A |title="Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study |journal=Ann. Intern. Med. |volume=165 |issue=8 |pages=533–542 |date=October 2016 |pmid=27479926 |pmc=5453639 |doi=10.7326/M16-0547 |url=}}</ref><ref name="pmid20823463">{{cite journal |vauthors=Nieman LK |title=Approach to the patient with an adrenal incidentaloma |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4106–13 |date=September 2010 |pmid=20823463 |pmc=2936073 |doi=10.1210/jc.2010-0457 |url=}}</ref><ref name="pmid23255953">{{cite journal |vauthors=Li B, Guo Q, Yang H, Guan J |title=Giant non-functional adrenal adenoma: A case report |journal=Oncol Lett |volume=5 |issue=1 |pages=378–380 |date=January 2013 |pmid=23255953 |pmc=3525484 |doi=10.3892/ol.2012.978 |url=}}</ref>
|
* Asymptomatic
* [[Abdominal]] [[pain]]
* [[Abdominal]] distenstion
* [[Nausea]]/[[vomiting]]
* Sub-clinical [[Cushing syndrome]]
* Sub-clinical [[hyperaldosteronism]]
|
* Asymptomatic
* [[Abdominal]] asymmetry
* [[Abdominal]] [[mass]]
* Sub-clinical [[Cushing syndrome]]
* Sub-clinical [[hyperaldosteronism]]
|
* N/L
* ↓ [[Adrenal]] [[hormones]]
* ↑ [[Serum]] [[cortisol]] (sub-clinical)
* ↑ [[Serum]] [[aldosterone]](sub-clinical)
* ↑ [[Serum]] [[androgens]] (sub-clinical)
|
* Well-defined margins
* Large monomorphic [[cells]]
* Abundant/foamy [[cytoplasm]]
* Typically resemble normal [[adrenal]] [[histology]]
* May see [[hemorrhage]] & [[necrosis]]
|
* [[Adrenal]] [[hormones]] levels
* [[Blood]] [[glucose]] level
* [[Plasma]] [[catecholamines]] and [[urinary]] [[metanephrines]]
* ARR
* [[Immunohistochemical staining]]
|
* Solid, well defined [[mass]]
|
* High [[lipid]] content and adjacent compression
|
* N/A
|
* Hyperintense on in-phase and hypointense on oppose-phase
|
* 2-fold increased risk for [[Diabetes mellitus]] in some studies
* Work up must exclude [[Cushing syndrome]], [[pheochromocytoma]] and [[adrenal carcinoma]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Adrenal [[Adrenal cancer|Carcinoma]]<br><ref name="pmid20823463">{{cite journal |vauthors=Nieman LK |title=Approach to the patient with an adrenal incidentaloma |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4106–13 |date=September 2010 |pmid=20823463 |pmc=2936073 |doi=10.1210/jc.2010-0457 |url=}}</ref><ref name="pmid26191527">{{cite journal |vauthors=Libé R |title=Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment |journal=Front Cell Dev Biol |volume=3 |issue= |pages=45 |date=2015 |pmid=26191527 |pmc=4490795 |doi=10.3389/fcell.2015.00045 |url=}}</ref><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid24423978">{{cite journal |vauthors=Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD |title=Adrenocortical carcinoma |journal=Endocr. Rev. |volume=35 |issue=2 |pages=282–326 |date=April 2014 |pmid=24423978 |pmc=3963263 |doi=10.1210/er.2013-1029 |url=}}</ref><ref name="pmid24102952">{{cite journal |vauthors=Wang C, Sun Y, Wu H, Zhao D, Chen J |title=Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers |journal=Histopathology |volume=64 |issue=4 |pages=567–76 |date=March 2014 |pmid=24102952 |pmc=4282325 |doi=10.1111/his.12283 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* [[Cortisol]]
* [[Aldosterone]]
* [[Androgens]]
* Non-functional
* [[Erythropoietin]]
|
* Symptoms of [[adrenal]] [[hormones]] excess as mentioned in [[adrenal adenoma]]
* Constitutional [[symptoms]] such as [[cachexia]], [[night sweats]], [[fever]]
* Localized [[symptoms]] such as [[abdominal]] [[pain]], [[mass]], fullness, early [[satiety]]
|
* [[Hypertension]]
* Signs of [[Adrenal gland|adrenal hormones]] excess as mentioned in [[adrenal adenoma]]
* Constitutional
* Localized [[signs]] such as [[abdominal]] [[mass]],[[abdominal]] [[distension]]
|
* N/L
* ↑ [[Serum]] [[cortisol]]
* ↑ [[Serum]] [[aldosterone]]
* ↑ [[Serum]] [[androgens]] 
* [[Hypokalemia]] 
* [[Alkalosis]]
* ↑ ARR
* ↑ [[Blood]] [[glucose]]
|
* Brown to orange to yellow
* [[Necrosis]] & [[mitosis]]
* [[Hypercellular]] & [[solid]] and/or diffuse [[growth]] pattern
* Low to high [[lipid]] content
* [[Nuclear]] [[pleomorphism]]
* Lymphovascular [[invasion]]
|
* [[Serum]] [[ACTH]]
* Low dose and high dose [[dexamethasone suppression test]]
* [[Urinary]] [[adrenal]] [[metabolites]]
* [[Spectroscopy|Proton MR spectroscopy]]
* [<sup>11</sup>C]MTO [[PET]]
* [[Immunohistochemical staining]]
|
* N/A
|
* Heterogeneous enhancement
|
* Heterogeneous mass with intense [[FDG]] uptake greater than [[liver]]
|
* Heterogenous hyper-intensity (T2-weighted) and hypo-intensity on (T1-weighted)
|
* May cause [[hypoglycemia]] (Anderson's syndrome}
* May be associated with:
** [[Hyperreninemic hypoaldosteronism|Hyperreninemic]]
** [[Hyperaldosteronism]]
** [[Erythropoietin]]-associated [[polycythemia]]
** [[Leukocytosis]]
|-
|-
|Capillary malformations
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Adrenal [[Adrenal hyperplasia|Hyperplasia]]<br><ref name="pmid25958045">{{cite journal |vauthors=Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P |title=Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas |journal=Mol. Cell. Endocrinol. |volume=411 |issue= |pages=146–54 |date=August 2015 |pmid=25958045 |pmc=4474471 |doi=10.1016/j.mce.2015.04.022 |url=}}</ref><ref name="pmid18493137">{{cite journal |vauthors=Stratakis CA |title=Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome) |journal=Endocr Dev |volume=13 |issue= |pages=117–32 |date=2008 |pmid=18493137 |pmc=3132884 |doi=10.1159/000134829 |url=}}</ref><ref name="pmid24605256">{{cite journal |vauthors=Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C |title=Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging |journal=J Clin Imaging Sci |volume=3 |issue= |pages=61 |date=2013 |pmid=24605256 |pmc=3935261 |doi=10.4103/2156-7514.124088 |url=}}</ref><ref name="pmid16278716">{{cite journal |vauthors=Arnold DT, Reed JB, Burt K |title=Evaluation and management of the incidental adrenal mass |journal=Proc (Bayl Univ Med Cent) |volume=16 |issue=1 |pages=7–12 |date=January 2003 |pmid=16278716 |pmc=1200803 |doi= |url=}}</ref><ref name="pmid23819074">{{cite journal |vauthors=Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J |title=Pure androgen-secreting adrenal adenoma associated with resistant hypertension |journal=Case Rep Endocrinol |volume=2013 |issue= |pages=356086 |date=2013 |pmid=23819074 |pmc=3681270 |doi=10.1155/2013/356086 |url=}}</ref><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid28707538">{{cite journal |vauthors=Michelle M A, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, Roman-Colon AM, Elsayes KM |title=Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics |journal=Br J Radiol |volume=90 |issue=1079 |pages=20170330 |date=November 2017 |pmid=28707538 |pmc=5963387 |doi=10.1259/bjr.20170330 |url=}}</ref><ref name="pmid26770569">{{cite journal |vauthors=Zhang Y, Li H |title=Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease |journal=Int J Clin Exp Med |volume=8 |issue=10 |pages=19311–7 |date=2015 |pmid=26770569 |pmc=4694469 |doi= |url=}}</ref>
Lymphatic malformations
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* [[Cortisol]] (most common)
* [[Aldosterone]]
* [[Androgens]]
* Non-functional
|
* Depending on the product secreted, may present as:
** [[Cushing syndrome]]
** [[Hyperaldosteronism]]
** [[Virilization]]
** [[Hirsutism]]
** [[Menstrual irregularities]]
** [[Testicular]] [[atrophy]]
** Diminished [[libido]]
* Localized [[symptoms]] such as [[abdominal]] [[pain]], [[mass]], [[fullness]], early [[satiety]]
|
* Depending on the product secreted, may present as:
** [[Cushing syndrome]]
** [[Hyperaldosteronism]]
** [[Virilization]]
** [[Hirsutism]]
** [[Menstrual irregularities]]
** [[Testicular]] [[atrophy]]
** [[Gynecomastia]]
* Localized [[symptoms]] such as [[abdominal]] [[pain]], [[mass]], [[fullness]], early [[satiety]]
|
* ↑ [[Serum]] [[cortisol]]
* ↑ [[Serum]] [[aldosterone]]
* ↑ [[Serum]] [[androgens]] 
* [[Hypokalemia]] 
* [[Alkalosis]]
* ↑ ARR
* ↑ [[Blood]] [[glucose]]
* ↑ [[Serum]] [[testosterone]]
* ↑ [[Serum]] [[androstenedione]]
* ↑ [[Serum]] [[dehydroepiandrosterone sulfate]] ([[DHEA-S]])
* ↑ [[Plasma]] and [[urine]] [[estrogens]]
|


Venous malformations
* Diffuse or [[nodular]] enlargement


Arteriovenous malformations*
* Increased thickness of [[zona reticularis]] and [[zona fasciculata]]
 
* Large polygonal [[cells]] with/without [[lipid]] depletion
Arteriovenous fistula*
* May contain [[pigment]] ([[lipofuscin]])
|Capillary venous malformation , Capillary lymphatic malformation
* [[endocrine]] [[atypia]]
Lymphatic venous malformation, Capillary lymphatic venous malformation
* Small [[nodules]]
 
|
Capillary arteriovenous malformation
* [[Adrenal venous sampling]]
 
* [[Pelvic]] & [[pituitary]] [[imaging]]
Capillary lymphatic arteriovenous malformation
* [[Genetic testing]]
 
* [[Fludrocortisone]] suppression testing
others
* [[Saline]] infusion testing
|See details
* Diurnal [[plasma]] [[cortisol]] variation
|See list
* Low dose and high dose [[dexamethasone suppression test]]
|}
* [[FSH]], [[LH]], [[prolactin]] levels
 
* [[Cortisol]] levels
° defined as two or more vascular malformations found in one lesion
|
 
* [[Adrenal]] [[mass]]
<nowiki>*</nowiki> high flow lesions
* Unilateral or bilateral [[adrenal]] enlargement or thickening
 
|
==Classification==
* Unilateral or bilateral [[adrenal]] enlargement or thickening
 
* [[Density]] is same as that of normal [[adrenal gland]]
===Classification of Vascular Malformations===
|
{{Family tree/start}}
* N/A
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | | | | | |A01= Vascular malformations}}
|
{{Family tree | | | | | | | | |,|-|-|-|-|-|-|-|-|-|v|-|-|-|-|-|^|-|-|-|-|-|v|-|-|-|-|-|-|-|-|-|.| | | | | | |}}
* Unilateral or bilateral [[adrenal]] enlargement or thickening
{{Family tree | | | | | | | | B01 | | | | | | | | B02 | | | | | | | | | | B03 | | | | | | | | B04 | | | | | |B01=Simple|B02=Combined|B03=of major named vessels|B04=asscoiated with other anomalies}}
* Signaling is same as that of normal [[adrenal gland]]
{{Family tree | | | | | | | | |!| | | | | | | | | |!| | | | | | | | | | | |!| | | | | | | | | |!| | | | | | |}}
|
{{Family tree | | | | | | | | |!| | | | | | | | | I02 | | | | | | | | | | I03 | | | | | | | | I04 | | | | | | |I02=Combined vascular malformations*
* [[Congenital adrenal hyperplasia]] presents in [[children]]/young adults
<table class="wikitable">
* Associated with [[Carney complex]]
<tr><td>'''CM + VM'''</td><td>Capillary-venous malformation</td><td>CVM</td></tr>
* [[Plasma]] levels of [[cortisol]] and [[ACTH]] may show false positive and false negative results due to normal diurnal [[hormonal]] variation
<tr><td>'''CM + LM'''</td><td>Capillary-lymphatic malformation</td><td>CLM</td></tr>
<tr><td>'''CM + AVM'''</td><td>Capillary-arteriovenous malformation</td><td>CAVM</td></tr>
<tr><td>'''LM + VM'''</td><td>Lymphatic-venous malformation</td><td>LVM</td></tr>
<tr><td>'''CM + LM + VM'''</td><td>Capillary-lymphatic-venous malformation</td><td>CLVM</td></tr>
<tr><td>'''CM + LM + AVM'''</td><td>Capillary-lymphatic-arteriovenous malformation</td><td>CLVM</td></tr>
<tr><td>'''CM + VM + AVM'''</td><td>Capillary-venous-arteriovenous malformation</td><td>CVAVM</td></tr>
<tr><td>'''CM + LM + VM + AVM'''</td><td>Capillary-lymphatic-venous-arteriovenous malformation</td><td>CLVAVM</td></tr>
</table>
|I03='''Anomalies of major named vessels'''<br>(also known as "channel type" or "truncal" vascular malformations)
|I04=Vascular malformations associated with other anomalies
<table class="wikitable">
<tr><td>'''Klippel-Trenaunay syndrome'''</td><td>CM + VM +/-LM + limb overgrowth</td></tr>
<tr><td>'''Parke's Weber syndrome'''</td><td>CM + AVF + limb overgrowth</td></tr>
<tr><td>'''Servelle-Martorell syndrome'''</td><td>Limb VM + bone undergrowth</td></tr>
<tr><td>'''Sturge-Weber syndrome'''</td><td>Facial + leptomeningeal CM + eye anomalies
+/-bone and/or soft tissue overgrowth</td></tr>
<tr><td>'''Maffucci syndrome'''</td><td>VM +/-spindle-cell hemangioma + enchondroma</td></tr>
<tr><td>'''CLOVES syndrome'''</td><td>LM + VM + CM +/-AVM+ lipomatous overgrowth</td></tr>
<tr><td>'''Proteus syndrome'''</td><td>CM, VM and/or LM + asymmetrical somatic overgrowth</td></tr>
<tr><td>'''Bannayan-Riley-Ruvalcaba sd'''</td><td>lower lip CM + face and neck LM + asymmetry and partial/generalized overgrowth</td></tr>
<tr><td>'''Limb CM + congenital non-progressive limb overgrowth'''</td><td></td></tr>
<tr><td>'''Macrocephaly-CM (M-CM / MCAP)'''</td><td></td></tr>
<tr><td>'''Microcephaly-CM (MICCAP)'''</td><td></td></tr>
</table>
|}}
{{Family tree | | | |,|-|-|-|-|+|-|-|-|-|v|-|-|-|-|v|-|-|-|-|.| | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | | C01 | | | C02 | | | C03 | | | C04 | | | C05 | | | | | | | | | | | | | | | | | | | | | | |C01=Capillary malformations|C02=Lymphatic malformations|C03=Venous malformations|C04=Arteriovenous malformations|C05=Arteriovenous fistula}}
{{Family tree | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | |)| D01 | |)| E01 | |)| F01 | |)| G01 | |)| H01 | | | | | | | | | | | | | | | | | | | | | |D01=Nevus simplex / salmon patch, “angel kiss”, “stork bite”|E01=Common (cystic) LM <br>Macrocystic  LM <br>Microcystic  LM <br>Mixed cystic LM|F01=Common VM|G01=Sporadic|H01=Sporadic}}
{{Family tree | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | |)| D02 | |)| E02 | |)| F02 | |)| G02 | |)| H02 | | | | | | | | | | | | | | | | | | | | | |D02=Cutaneous and/or mucosal CM (also known as “port-wine” stain) <br>Nonsyndromic CM <br>CM with CNS and/or ocular anomalies (Sturge-Weber syndrome) <br>CM with bone and/or soft tissues overgrowth <br>Diffuse CM with overgrowth (DCMO)|E02=Generalized lymphatic anomaly (GLA) <br>Kaposiform lymphangiomatosis (KLA)|F02=Familial VM cutaneo-mucosal (VMCM)|G02=In HHT|H02=In HHT|}}
{{Family tree | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | |)| D03 | |)| E03 | |)| F03 | |)| G03 | |)| H03 | | | | | | | | | | | | | | | | | | | | | |D03=Reticulate CM <br>CM of MIC-CAP (microcephaly-capillary malformation) <br>CM of MCAP (megalencephaly-capillary malformation-polymicrogyria)|E03=LM in Gorham-Stout disease|F03=Blue rubber bleb nevus (Bean) syndrome VM|G03=In CM-AVM|H03=In CM-AVM|}}
{{Family tree | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | |)| D04 | |)| E04 | |)| F04 | |`| G04 | |`| H04 | | | | | | | | | | | | | | | | | | | | | |D04=CM of CM-AVM|E04=Channel type LM|F04=Glomuvenous malformation (GVM)|G04=Others|H04=Others|}}
{{Family tree | | |!| | | | |!| | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | |)| D05 | |)| E05 | |)| F05 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |D05=Cutis marmorata telangiectatica congenita (CMTC)|E05=“Acquired” progressive lymphatic anomaly (so called acquired progressive "lymphangioma")|F05=Cerebral cavernous malformation (CCM) |}}
{{Family tree | | |!| | | | |!| | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | |)| D06 | |)| E06 | |)| F06 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |D06=Others|E06=Primary lymphedema |F06=Familial intraosseous vascular malformation (VMOS)|}}
{{Family tree | | |!| | | | |!| | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | |`| D07 | |`| E07 | |)| F07 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |D07=Telangiectasia <br>Hereditary hemorrhagic telangiectasia (HHT) <br>Others|E07=Others|F07=Verrucous venous malformation (formerly verrucous hemangioma)|}}
{{Family tree | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | | | | | | | | | | | |`| F08 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |F08=Others|}}
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree/end}}
 
===Tables===
{| class="wikitable" style="text-align:left"
|+
|+
!Anomalies of major named vessels
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Medulla
(also known as "channel type" or "truncal" vascular malformations)
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnosis
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
|-
|-
|Affect
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptoms
  lymphatics
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Signs
  veins
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
  arteries
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
 
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
Anomalies of
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Ultrasound
  origin
! style="background:#4479BA; color: #FFFFFF;" align="center" + |CT scan
  course
! style="background:#4479BA; color: #FFFFFF;" align="center" + |FDG PET/CT
  number
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MRI
  length
  diameter (aplasia, hypoplasia, stenosis, ectasia / aneurysm)
  valves
  communication (AVF)
  persistence (of embryonal vessel)
|}
 
{|class="wikitable"
! colspan="3" |Combined vascular malformations*
|-
|-
|CM + VM
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pheochromocytoma]]<br><ref name="pmid24636754">{{cite journal |vauthors=Martucci VL, Pacak K |title=Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment |journal=Curr Probl Cancer |volume=38 |issue=1 |pages=7–41 |date=2014 |pmid=24636754 |pmc=3992879 |doi=10.1016/j.currproblcancer.2014.01.001 |url=}}</ref><ref name="pmid20541673">{{cite journal |vauthors=Kantorovich V, Pacak K |title=Pheochromocytoma and paraganglioma |journal=Prog. Brain Res. |volume=182 |issue= |pages=343–73 |date=2010 |pmid=20541673 |pmc=4714594 |doi=10.1016/S0079-6123(10)82015-1 |url=}}</ref><ref name="pmid19605896">{{cite journal |vauthors=Miller AD, Masek-Hammerman K, Dalecki K, Mansfield KG, Westmoreland SV |title=Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus) |journal=Vet. Pathol. |volume=46 |issue=6 |pages=1221–9 |date=November 2009 |pmid=19605896 |doi=10.1354/vp.09-VP-0022-M-FL |url=}}</ref><ref name="pmid19120142">{{cite journal |vauthors=Kantorovich V, Eisenhofer G, Pacak K |title=Pheochromocytoma: an endocrine stress mimicking disorder |journal=Ann. N. Y. Acad. Sci. |volume=1148 |issue= |pages=462–8 |date=December 2008 |pmid=19120142 |pmc=2693284 |doi=10.1196/annals.1410.081 |url=}}</ref><ref name="pmid25332315">{{cite journal |vauthors=Eisenhofer G, Peitzsch M |title=Laboratory evaluation of pheochromocytoma and paraganglioma |journal=Clin. Chem. |volume=60 |issue=12 |pages=1486–99 |date=December 2014 |pmid=25332315 |doi=10.1373/clinchem.2014.224832 |url=}}</ref>
|capillary-venous malformation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
|CVM
* [[Catecholamines]]
|
*[[Headaches]]
*[[Palpitations]]
*Excessive [[sweating]]
*[[Anxiety]]
*[[Pallor]]
*Pain in [[chest]]/[[abdomen]]
*[[Weakness]], [[fatigue]]
*[[Nausea]]/[[vomiting]]
*[[Dizziness]]
*[[Paresthesias]]
*[[Constipation]] (rarely [[diarrhea]])
*[[Visual disturbance]]
|
*[[Hypertension]]
*Postural [[hypotension]]
*[[Tachycardia]] or reflex [[bradycardia]]
*Tremulousness
*[[Pallor]]
*[[Flushing]] (rare)
*[[Weight]] loss
*Fasting [[hyperglycaemia]]
*Decreased [[GI]] [[motility]]
*[[Pallor]]
*↑ [[Respiratory rate]]
*[[Psychosis]]
|
* ↑ [[Plasma]] and [[urine]] [[catecholamines]] (Gold standard)
* ↑ [[Plasma]] and [[urine]] [[metanephrines]] (Gold standard)
* ↑ [[Chromogranin A]]
* ↑ [[Plasma]] [[methoxytyramine]]
|
*Loosely cohesive clusters
*Scattered [[tumor]] [[cells]] with prominent anisokaryosis, abundant [[eosinophilic]] granular [[cytoplasm]] and indistinct [[cell]] borders
*Occasional bi-nucleate [[cells]]
|
*Genetic testing
*Provacative [[glucagon]] test
*[[Clonidine]] suppression test
*Metaiodobenzyl-guanidine [[scintigraphy]]
*[[PET]] scan
*[[Octereoscan]]
|
*[[Cystic]] or solid with [[necrotic]] areas or [[hemorrhages]]
|
* Heterogeneous appearance, often with some [[cystic]] areas.
* [[Calcification]] or [[hemorrhage]] may also be present
|
* N/A
|
* T2-bright lesions, with/without [[cystic]] or [[necrotic]] components
|
*May mimic [[panic attack]]
*May be associated with  [[Von Hippel-Lindau disease]],  [[MEN type 2]] and [[neurofibromatosis type 1]].
*Arise from the [[chromaffin cells]]
*[[Stain|Stains]] positive for
** [[Chromogranin A]] (CGA)
** Protein gene product (PGP) 9.5
** [[Synaptophysin]] (SYN)
** [[CD56]] ([[CAM|N-CAM]])
** [[Glial fibrillary acidic protein]] ([[GFAP]])
|-
|-
|CM + LM
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neuroblastoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid25154816">{{cite journal |vauthors=Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG |title=Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project |journal=J. Clin. Oncol. |volume=32 |issue=28 |pages=3169–76 |date=October 2014 |pmid=25154816 |pmc=4171360 |doi=10.1200/JCO.2014.56.1621 |url=}}</ref><ref name="pmid25254086">{{cite journal |vauthors=Bordbar M, Tasbihi M, Kamfiroozi R, Haghpanah S |title=Epidemiological and clinical characteristics of neuroblastoma in southern iran |journal=Iran J Ped Hematol Oncol |volume=4 |issue=3 |pages=89–96 |date=2014 |pmid=25254086 |pmc=4173027 |doi= |url=}}</ref><ref name="pmid24563879">{{cite journal |vauthors=Skoura E, Oikonomopoulos G, Vasileiou S, Kyprianou D, Koumakis G, Datseris IE |title=(18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma |journal=Hell J Nucl Med |volume=17 |issue=1 |pages=58–61 |date=2014 |pmid=24563879 |doi=10.1967/s002449910116 |url=}}</ref>
|capillary-lymphatic malformation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
|CLM
* [[Catecholamines]]
|
* Constitutional
* Failure to thrive
* [[Abdominal]] [[pain]]
* [[Diarrhea]]
* [[Constipation]]
* [[Dyspnea]]
* Prolonged [[cough]]
* [[Strabismus]]
* [[Proptosis]]
|
* [[Abdominal]] [[mass]]
* [[Pallor]]
* [[Tachycardia]]
* [[Hypertension]]
* Failure to thrive
* [[Strabismus]]
* [[Proptosis]]
|
* N/L
* Slight elevation in [[catecholamines]]
* ↑ [[Urinary]] [[metanephrines]]
* [[Anemia]]
* ↑ [[Ferritin]]
* ↑ [[LDH]]
* [[Thrombocytosis]]
|
* Pathological examinations are gold standard.
* Cells may show:
** Undifferentiation
** Poor differentiation
** Differentiating [[neuroblasts]]
* [[Necrosis]]
* Salt and pepper [[chromatin]]
* [[Spindle]]-like [[fibers]]
|
* [[Immunohistochemical staining]]
* [[PET]] scan
*[[Octereoscan]]
*<sup>131</sup>I-metaiodobenzylguanidine (MIBG) [[scintigraphy]]
*[[FISH]]
*[[Genetic testing]]
|
* Large mass
* May cross midline
|
* Large mass extending across the midline
* Heterogeneous enhancement
* [[Calcification]] & [[hemorrhage]]
|
* N/A
|
* [[Calcification]] & [[hemorrhage]]
* Non-homogeneous and hyperintense
* Hypointense (T1-weighted)
|[[Stain|Stains]] positive for:
* [[Chromogranin A]] (CGA)
* Protein gene product (PGP) 9.5
* [[Neuron-specific enolase]]
* [[Synaptophysin]] ([[Synaptophysin|SYN]])
* [[CD56]] & [[CD57]]
* [[Glial fibrillary acidic protein]] ([[GFAP]])
 
*
|-
|-
|CM + AVM
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ganglioneuroma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid29085827">{{cite journal |vauthors=Mylonas KS, Schizas D, Economopoulos KP |title=Adrenal ganglioneuroma: What you need to know |journal=World J Clin Cases |volume=5 |issue=10 |pages=373–377 |date=October 2017 |pmid=29085827 |pmc=5648998 |doi=10.12998/wjcc.v5.i10.373 |url=}}</ref><ref name="pmid24779851">{{cite journal |vauthors=Adas M, Koc B, Adas G, Ozulker F, Aydin T |title=Ganglioneuroma presenting as an adrenal incidentaloma: a case report |journal=J Med Case Rep |volume=8 |issue= |pages=131 |date=April 2014 |pmid=24779851 |pmc=4031973 |doi=10.1186/1752-1947-8-131 |url=}}</ref><ref name="pmid23661526">{{cite journal |vauthors=Li J, Yang CH, Li LM |title=Diagnosis and treatment of 29 cases of adrenal ganglioneuroma |journal=Eur Rev Med Pharmacol Sci |volume=17 |issue=8 |pages=1110–3 |date=April 2013 |pmid=23661526 |doi= |url=}}</ref>
|capillary-arteriovenous malformation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
|CAVM
* [[Catecholamines]]
* [[VIP]]
* [[Cortisol]]
* [[Androgens]]
|
* Asymptomatic
* [[Abdominal]] [[pain]]
* [[Diarrhea]]
|
* N/L
* [[Abdominal]] [[mass]]
* [[Hypertension]]
|
* N/L
* ↑ [[Plasma]] and [[urinary]] [[catecholamine]]
* ↑ [[VIP]]
* ↑ [[Cortisol]] and [[testosterone]]
|
* Pathological examinations are gold standard.
* Mature type: mature [[Schwann cells]], [[ganglion cells]] and peri-[[neural]] [[cells]]
* Maturing type: [[Schwann cells]], [[ganglion cells]] and peri-[[neural]] [[cells]] with varying [[maturation]]
|
* Pathological examinations are gold standard.
* [[Ultrasound]]
* [[Immunohistochemical staining]]
* <sup>18</sup>F-2-fluoro-deoxy-D-glucose-[[positron emission tomography]] ([[PET]])
|
* N/A
|
* Well-defined, Homogeneous
* Punctate or discrete [[calcification]]
|
* N/A
|
* Hypointense (T1-weighted)
* Varied signal (T2-weighted)
|
[[Stain|Stains]] positive for:
* [[S-100|S100]]
* [[Synaptophysin]]
* [[Neurofilament]] ([[NF]]) [[protein]]
* [[Chromogranin A]]
* [[Glial fibrillary acidic protein]]
* PGP 9.5
* [[Type IV collagen]]
* [[VIP]]
|+
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Stroma
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnosis
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
|-
|-
|LM + VM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptoms
|lymphatic-venous malformation
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Signs
|LVM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Ultrasound
! style="background:#4479BA; color: #FFFFFF;" align="center" + |CT scan
! style="background:#4479BA; color: #FFFFFF;" align="center" + |FDG PET/CT
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MRI
|+
|-
|-
|CM + LM + VM
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lipoma]]/[[Myolipoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid11533079">{{cite journal |vauthors=Lam KY, Lo CY |title=Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution |journal=J. Clin. Pathol. |volume=54 |issue=9 |pages=707–12 |date=September 2001 |pmid=11533079 |pmc=1731508 |doi= |url=}}</ref><ref name="pmid24328509">{{cite journal |vauthors=Gershuni VM, Bittner JG, Moley JF, Brunt LM |title=Adrenal myelolipoma: operative indications and outcomes |journal=J Laparoendosc Adv Surg Tech A |volume=24 |issue=1 |pages=8–12 |date=January 2014 |pmid=24328509 |pmc=3931430 |doi=10.1089/lap.2013.0411 |url=}}</ref><ref name="pmid26464739">{{cite journal |vauthors=Luo J, Chen L, Wen Q, Xu L, Chu S, Wang W, Alnemah MM, Fan S |title=Lipoadenoma of the adrenal gland: report of a rare entity and review of literature |journal=Int J Clin Exp Pathol |volume=8 |issue=8 |pages=9693–7 |date=2015 |pmid=26464739 |pmc=4583971 |doi= |url=}}</ref>
|capillary-lymphatic-venous malformation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
|CLVM
* N/A
|
* Asymptomatic
* [[Abdominal]] [[pain]]
* Back [[pain]]
* [[Fever]]
|
* N/L
* [[Abdominal]] [[mass]]
* [[Fever]]
|
* N/L
|
* Pathological examinations are gold standard.
* Yellow [[adipose tissue]]
* [[Hemorrhagic]] foci
* Islands of [[Hematopoiesis lineages|hematopoietic cells]] ([[myolipoma]]) and mature [[fat cells]] ([[Lipoma]])
|
* [[Renal function tests|RFTs]]
* [[LFTs]]
* [[Urinalysis|Urine analysis]]
* [[Ultrasound]]
|
* Heterogeneous [[mass]]
|
* [[Retro-peritoneal]] [[mass]]
* Well-defined heterogenous enhancement
|
* N/A
|
* High signal
|
* [[Myolipoma]]: mature [[adipose tissue]] and [[haematopoietic]]  elements
* [[Lipoma]]: mature [[fat cells]]
|+
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnosis
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
|-
|-
|CM + LM + AVM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptoms
|capillary-lymphatic-arteriovenous malformation
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Signs
|CLAVM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Ultrasound
! style="background:#4479BA; color: #FFFFFF;" align="center" + |CT scan
! style="background:#4479BA; color: #FFFFFF;" align="center" + |FDG PET/CT
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MRI
|-
|-
|CM + VM + AVM
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tuberculosis]]<br><ref name="pmid27006656">{{cite journal |vauthors=Rodríguez-Gutiérrez R, Rendon A, Barrera-Sánchez M, Carlos-Reyna KE, Álvarez-Villalobos NA, González-Saldivar G, González-González JG |title=Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test |journal=Int J Endocrinol |volume=2016 |issue= |pages=9051865 |date=2016 |pmid=27006656 |pmc=4781954 |doi=10.1155/2016/9051865 |url=}}</ref><ref name="pmid15451821">{{cite journal |vauthors=Haddara WM, van Uum SH |title=TB and adrenal insufficiency |journal=CMAJ |volume=171 |issue=7 |pages=710; author reply 710–1 |date=September 2004 |pmid=15451821 |pmc=517840 |doi=10.1503/cmaj.1041046 |url=}}</ref><ref name="pmid26516430">{{cite journal |vauthors=Huang YC, Tang YL, Zhang XM, Zeng NL, Li R, Chen TW |title=Evaluation of primary adrenal insufficiency secondary to tuberculous adrenalitis with computed tomography and magnetic resonance imaging: Current status |journal=World J Radiol |volume=7 |issue=10 |pages=336–42 |date=October 2015 |pmid=26516430 |pmc=4620114 |doi=10.4329/wjr.v7.i10.336 |url=}}</ref><ref name="pmid28233510">{{cite journal |vauthors=Vinnard C, Blumberg EA |title=Endocrine and Metabolic Aspects of Tuberculosis |journal=Microbiol Spectr |volume=5 |issue=1 |pages= |date=January 2017 |pmid=28233510 |doi=10.1128/microbiolspec.TNMI7-0035-2016 |url=}}</ref><ref name="pmid23687365">{{cite journal |vauthors=Rajasekharan C, Ajithkumar S, Anto V, Parvathy R |title=Extrapulmonary disseminated tuberculosis with tuberculous adrenalitis: a stitch in time saves nine |journal=BMJ Case Rep |volume=2013 |issue= |pages= |date=May 2013 |pmid=23687365 |doi=10.1136/bcr-2012-008011 |url=}}</ref>
|capillary-venous-arteriovenous malformation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
|CVAVM
* N/A
|
* [[Weakness]]
* [[Malaise]]
* [[Nausea]]
* [[Fatigue]]
* [[Anorexia]]
* [[Abdominal]] [[pain]]
* [[Orthostatic hypotension]]
* [[Constipation]]
* [[Salt]] craving
* [[Adrenal crisis]]
* [[Symptoms]] of [[pulmonary]] [[TB]]
|
* [[Weight loss]]
* [[Hyperpigmentation]] of the [[skin]]
* [[Fever]]
* [[Hypotension]]
* [[Adrenal crisis]]
* [[Signs]] of [[pulmonary tuberculosis]]
|
* [[Anemia]]
* [[Leukocytosis]]
* [[Hyponatremia]]
* [[Hyperkalemia]]
* [[Hypoglycemia]]
* Low early morning [[serum]] [[cortisol]] levels
* Low basal [[urinary]] [[cortisol]]
* ↑ [[ACTH]]
* ↓ [[Aldosterone]]
* ↑ [[Plasma]] [[renin]]
|
* Enlarged, [[necrotic]] [[adrenal glands]]
* Central [[caseous necrosis]]
* Rim of [[granulomatous]] [[inflammatory cells]] ([[Langerhans giant cells]] and [[lymphocytes]])
* Identifiable [[Acid fast|acid-fast stain]]-positive [[bacteria]] with [[Ziehl-Neelsen stain|Ziehl-Neelsen]] or [[Immunofluorescence|fluorescent stains]]
|
* [[Laparoscopic]] [[adrenalectomy]]
* [[Chest X-ray]]
* [[Chest]] [[CT scan]]
* [[Tuberculin test]]
* [[ACTH]] stimulation test
* [[Insulin]] induced [[hypoglycemia]]
* [[Metyrapone]] stimulation tests
|
* Variable
|
* [[Calcification]]
* Hypodense areas
* Rim enhancement
|
* High [[FDG]] uptake by [[adrenal glands]]
|
* [[Calcification]]
* Variable signals
|
* Majority of the cases are secondary to:
** [[Pulmonary TB]]
** [[Genitourinary]] [[TB]]
** [[HIV]] [[infection]]
* May present with [[shock]] with severe [[hypotension]] and [[hypoglycemia]] due to [[glucocorticoid]] insufficiency
|-
|-
|CM + LM + VM + AVM
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Histoplasmosis]]<br><ref name="pmid27995051">{{cite journal |vauthors=Rog CJ, Rosen DG, Gannon FH |title=Bilateral adrenal histoplasmosis in an immunocompetent man from Texas |journal=Med Mycol Case Rep |volume=14 |issue= |pages=4–7 |date=December 2016 |pmid=27995051 |pmc=5154969 |doi=10.1016/j.mmcr.2016.11.006 |url=}}</ref><ref name="pmid27047312">{{cite journal |vauthors=Wahab NA, Mohd R, Zainudin S, Kamaruddin NA |title=Adrenal involvement in histoplasmosis |journal=EXCLI J |volume=12 |issue= |pages=1–4 |date=2013 |pmid=27047312 |pmc=4817423 |doi= |url=}}</ref><ref name="pmid29888193">{{cite journal |vauthors=May D, Khaled D, Gills J |title=Unilateral adrenal histoplasmosis |journal=Urol Case Rep |volume=19 |issue= |pages=54–56 |date=July 2018 |pmid=29888193 |pmc=5991316 |doi=10.1016/j.eucr.2018.03.010 |url=}}</ref><ref name="pmid29643659">{{cite journal |vauthors=Gupta RK, Majumdar K, Srivastava S, Varakanahalli S, Saran RK |title=Endoscopic Ultrasound-guided Cytodiagnosis of Adrenal Histoplasmosis with Reversible CD4 T-Lymphocytopenia and Jejunal Lymphangiectasia |journal=J Cytol |volume=35 |issue=2 |pages=110–113 |date=2018 |pmid=29643659 |pmc=5885598 |doi=10.4103/JOC.JOC_234_15 |url=}}</ref><ref name="pmid25027093">{{cite journal |vauthors=Padma S, Sreehar S |title=18F FDG PET/CT identifies unsuspected bilateral adrenal histoplasmosis in an elderly immuno compromised patient |journal=Indian J. Med. Res. |volume=139 |issue=5 |pages=786–7 |date=May 2014 |pmid=25027093 |pmc=4140048 |doi= |url=}}</ref>
|capillary-lymphatic-venous-arteriovenous m.
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
|CLVAVM
* N/A
|}
|
* No [[adrenal]] s[[ymptoms]]
* [[Adrenal insufficiency]]:
** [[Weakness]] & [[malaise]]
** [[Nausea]], [[fatigue]] and [[anorexia]]
** [[Abdominal]] [[pain]]
** [[Orthostatic hypotension]]
** [[Constipation]]
** [[Salt]] craving
* [[Symptoms]] of [[pulmonary]]/[[skin]]/[[bone]] [[histoplasmosis]]
|
* [[Weight loss]]
* [[Hyperpigmentation]] of the [[skin]]
* [[Fever]]
* [[Hypotension]]
* [[Adrenal crisis]]
* [[Signs]] of [[pulmonary]]/[[skin]]/[[bone]] [[histoplasmosis]]
|
* [[Anemia]]
* [[Leukocytosis]]
* [[Hyponatremia]]
* [[Hyperkalemia]]
* [[Hypoglycemia]]


 
* Low early morning [[serum]] [[cortisol]] levels
{| class="wikitable" style="text-align:center"
* Low basal [[urinary]] [[cortisol]]
! colspan="3" |Vascular malformations associated with other anomalies
* ↑ [[ACTH]]
* ↓ [[Aldosterone]]
* ↑ [[Plasma]] [[renin]]
|
* [[Necrotizing]] [[granulomatous]] [[inflammation]] similar to [[tuberculosis]]
* [[Capsulated]] [[yeast]] forms of ''[[Histoplasma]]'' ([[Giemsa stain]])
* ''[[Histoplasma]]'' identification ([[H&E stain]])
* Focal ovoid bodies with a clear halo ([[PAS stain]])
|
* [[Ultrasound]]-guided [[fine needle aspiration]] [[cytology]] ([[Ultrasound|USG]]-[[FNA|FNAC]]) is gold standard.
* [[Laparoscopic]] [[adrenalectomy]]
* [[Endoscopic ultrasound]]
* [[Ultrasound|Abdominal ultrasound]]
* [[Chest X-ray]]
* [[ACTH]] stimulation test
* [[Metyrapone]] stimulation tests
|
* Enlarged [[adrenal glands]]
* [[Calcification]]
|
* Enlarged [[adrenal glands]]
* [[Calcification]]
* Heterogeneous enhancement
|
* Abnormal [[FDG]] uptake by [[adrenal glands]]
|
* Enlarged [[adrenal glands]]
* [[Calcification]]
* Isointense [[adrenal]] [[mass]] ([[MRI]])
|
* [[Patient]] may exhibit no [[clinical manifestations]] of [[adrenal]] involvement
* Majority of the cases are secondary to:
** [[Pulmonary]] [[histoplasmosis]]
** [[HIV]] [[infection]]
* May present with [[shock]] with severe [[hypotension]] and [[hypoglycemia]] due to [[glucocorticoid]] insufficiency
|-
|-
| colspan="2" |Klippel-Trenaunay syndrome *
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cysts]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid28246490">{{cite journal |vauthors=Carsote M, Ghemigian A, Terzea D, Gheorghisan-Galateanu AA, Valea A |title=Cystic adrenal lesions: focus on pediatric population (a review) |journal=Clujul Med |volume=90 |issue=1 |pages=5–12 |date=2017 |pmid=28246490 |doi=10.15386/cjmed-677 |url=}}</ref><ref name="pmid26807295">{{cite journal |vauthors=Słapa RZ, Jakubowski WS, Dobruch-Sobczak K, Kasperlik-Załuska AA |title=Standards of ultrasound imaging of the adrenal glands |journal=J Ultrason |volume=15 |issue=63 |pages=377–87 |date=December 2015 |pmid=26807295 |pmc=4710689 |doi=10.15557/JoU.2015.0035 |url=}}</ref><ref name="pmid29881567">{{cite journal |vauthors=Olaoye IO, Adesina MD, Afolayan EA |title=A giant adrenal cyst with an uncertain preoperative diagnosis causing a dilemma in management |journal=Clin Case Rep |volume=6 |issue=6 |pages=1074–1076 |date=June 2018 |pmid=29881567 |pmc=5986023 |doi=10.1002/ccr3.1519 |url=}}</ref>
|CM + VM +/-LM + limb overgrowth
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
|
* [[Abdominal]] [[pain]]
* [[Abdominal Aortic Aneurysm|Abdominal]] [[mass]]
* [[Abdominal]] fullness
* [[Hematuria]]
* [[Infection]]
* [[Symptoms]] of [[malignancy]] ([[Cystic]] part of other [[tumors]])
|
* [[Abdominal]] [[mass]] & assymetry
* [[Fever]]
* [[Hypertension]] ([[Renal]] compression)
* [[Hypotension]] ([[Hemorrhage]] into [[cyst]])
* [[Signs]] of [[malignancy]] ([[Cystic]] part of other [[tumors]])
|
* N/L
* [[Anemia]]
* [[Leukocytosis]]
|
* [[Vascular]] or [[endothelial]] [[cyst]]: lined by flattened [[endothelial cells]]
* [[Epithelial]]: lined by [[epithelium]]
* [[Pseudocyst]]: lined by [[fibrous tissue]]
* [[Hydatid cyst]]: 3 layers (germinal layer, laminated [[membrane]] and dense [[fibrovascular tissue]])
|
* Complete [[endocrine]] panel
* [<sup>18</sup>F][[FDG]] [[PET]]/[[CT]] (if [[malignancy]] is suspected)
* [[Biopsy]] (if [[malignancy]] is suspected)
* [[ACTH]] stimulation test
|
* Gold standard
* Circumscribed anechoic or hypoechoic mass
|
* Homogeneous [[mass]]
* No enhancement
* [[Calcification]]
* Low density
|
* N/A
|
* High signal
|
* 3 major subtypes
** Pure [[cysts]] ([[vascular]] or [[endothelial]] [[cyst]], [[pseudocyst]] and 'true' [[epithelial]] [[cysts]])
** [[Parasitic cysts]]
** [[Cystic]] part of an otherwise solid [[tumor]]
|-
|-
| colspan="2" |Parkes Weber syndrome
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hematoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid14747454">{{cite journal |vauthors=Hamilton D, Harris MD, Foweraker J, Gresham GA |title=Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection |journal=J. Clin. Pathol. |volume=57 |issue=2 |pages=208–9 |date=February 2004 |pmid=14747454 |pmc=1770213 |doi= |url=}}</ref><ref name="pmid28828107">{{cite journal |vauthors=Di Serafino M, Severino R, Coppola V, Gioioso M, Rocca R, Lisanti F, Scarano E |title=Nontraumatic adrenal hemorrhage: the adrenal stress |journal=Radiol Case Rep |volume=12 |issue=3 |pages=483–487 |date=September 2017 |pmid=28828107 |pmc=5551907 |doi=10.1016/j.radcr.2017.03.020 |url=}}</ref><ref name="pmid29770310">{{cite journal |vauthors=Ierardi AM, Petrillo M, Patella F, Biondetti P, Fumarola EM, Angileri SA, Pesapane F, Pinto A, Dionigi G, Carrafiello G |title=Interventional radiology of the adrenal glands: current status |journal=Gland Surg |volume=7 |issue=2 |pages=147–165 |date=April 2018 |pmid=29770310 |pmc=5938278 |doi=10.21037/gs.2018.01.04 |url=}}</ref>
|CM + AVF + limb overgrowth
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
|
* [[Flank]]/back [[pain]]
* [[Weakness]]
* [[Hypovolemic shock]]
* [[Adrenal crisis]] (massive [[hemorrhage]])
* [[Adrenal insufficiency]]
* [[Symptoms]] of underlying [[cause]]
|
* [[Hypotension]]
* [[Abdominal]]/[[flank]] [[mass]]
* [[Hypovolemic shock]]
* [[Adrenal crisis]] (massive [[hemorrhage]])
* [[Adrenal insufficiency]]
* [[Signs]] of underlying cause
|
* [[Anemia]]
* ↓ [[Serum]] and [[urinary]] [[Adrenal Gland|adrenal hormones]] and [[metabolites]]
* Findings related to underlying cause
|
* [[Pseudocyst]]: lined by [[fibrous tissue]]
* Findings related to underlying cause
|
* [[Adrenal]] [[ultrasound]]
* [[ACTH]] stimulation test
* Tests related to underlying cause
|
* Variable
|
* High density (acute [[hemorrhage]])
|
* N/A
|
* Isointense and low signal (Early [[hemorrhage]])
* Hypointense (Late [[hemorrhage]])
|
* Majority of the cases in [[neonantal]] peiod
* Majority of the cases caused by [[trauma]]
|-
|-
| colspan="2" |Servelle-Martorell syndrome
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemangioma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid22701011">{{cite journal |vauthors=Alhajri K, Alhasan I, Alzerwi N, Abudaff N |title=Adrenal haemangioma |journal=BMJ Case Rep |volume=2011 |issue= |pages= |date=April 2011 |pmid=22701011 |pmc=3079485 |doi=10.1136/bcr.12.2010.3604 |url=}}</ref><ref name="pmid29560018">{{cite journal |vauthors=Iwamoto G, Shimokihara K, Kawahara T, Takamoto D, Yao M, Teranishi JI, Otani M, Uemura H |title=Adrenal Hemangioma: A Case of Retroperitoneal Tumor |journal=Case Rep Med |volume=2018 |issue= |pages=8796327 |date=2018 |pmid=29560018 |pmc=5836307 |doi=10.1155/2018/8796327 |url=}}</ref><ref name="pmid26600897">{{cite journal |vauthors=Tarchouli M, Boudhas A, Ratbi MB, Essarghini M, Njoumi N, Sair K, Zentar A |title=Giant adrenal hemangioma: Unusual cause of huge abdominal mass |journal=Can Urol Assoc J |volume=9 |issue=11-12 |pages=E834–6 |date=2015 |pmid=26600897 |pmc=4639440 |doi=10.5489/cuaj.2967 |url=}}</ref>
|limb VM + bone undergrowth
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* [[Cortisol]] (rare)
* [[Aldosterone]] (rare)
* [[Androgens]] (rare)
|
* [[Abdominal]] [[mass]] & discomfort
* [[Nausea]] & [[vomiting]]
* Back [[pain]]
* [[Hypovolemic shock]] ([[hemorrhage]])
* [[Symptoms]] of [[hormonal]] excess (very rare)
|
* [[Abdominal]] [[mass]]
* [[Hypovolemic shock]] ([[hemorrhage]])
* [[Symptoms]] of [[hormonal]] excess (very rare)
|
* N/L
* [[Anemia]] ([[hemorrhage]])
* ↑ [[Serum]] and [[urinary]] [[Adrenal gland|adrenal hormones]] and [[metabolites]] (very rare)
|
* [[Histopathology]] is gold standard
* Most often [[cavernous]]
* Peripheral dilated [[vascular]] spaces
* Monostromatic [[endothelium]]
* Absence of [[atypia]]
* Central [[necrosis]]
* [[Calcification]]
* [[Hemorrhage]]
|
* Complete [[endocrine]] panel
* [[Ultrasound]]
* [[FDG]]-[[PET]] scan
* [[Endoscopic ultrasound]]
* Post-[[resection]] [[biopsy]] (if [[malignancy]] is suspected)
|
* [[Calcification]]
* [[Phleboliths]]
|
* [[Calcification]]
* [[Phleboliths]]
* Irregular peripheral enhancement
|
* N/A
|
* Hyperintensity (T2) hypointensity (T1)
* Peripheral spotty and centripetal enhancement
|
* Majority of the cases diagnosed incidentally
* Majority of the [[lesions]] are non-functional with [[female]] pre-dominance
|-
|-
| colspan="2" |Sturge-Weber syndrome
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid28794358">{{cite journal |vauthors=Harada K, Kimura K, Iwamuro M, Terasaka T, Hanayama Y, Kondo E, Hayashi E, Yoshino T, Otsuka F |title=The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency |journal=Intern. Med. |volume=56 |issue=17 |pages=2261–2269 |date=September 2017 |pmid=28794358 |pmc=5635296 |doi=10.2169/internalmedicine.8216-16 |url=}}</ref><ref name="pmid27795295">{{cite journal |vauthors=Laurent C, Casasnovas O, Martin L, Chauchet A, Ghesquieres H, Aussedat G, Fornecker LM, Bologna S, Borot S, Laurent K, Bouillet B, Verges B, Petit JM |title=Adrenal lymphoma: presentation, management and prognosis |journal=QJM |volume=110 |issue=2 |pages=103–109 |date=February 2017 |pmid=27795295 |doi=10.1093/qjmed/hcw174 |url=}}</ref><ref name="pmid29344029">{{cite journal |vauthors=Karimi F |title=Primary Adrenal Lymphoma Presenting with Adrenal Failure: A Case Report and Review of the Literature |journal=Int J Endocrinol Metab |volume=15 |issue=4 |pages=e12014 |date=October 2017 |pmid=29344029 |pmc=5750783 |doi=10.5812/ijem.12014 |url=}}</ref>
|facial + leptomeningeal CM + eye anomalies
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
+/-bone and/or soft tissue overgrowth
* N/A
|
* [[Fatigue]]
* Loss of [[appetite]]
* [[Weight loss]]
* [[Pigmentation]] of [[skin]]
* [[Flank]]/[[abdominal]] [[pain]]
* [[Fever]]
* [[Nausea]] & [[vomiting]]
|
* [[Hypotension]]
* [[Altered mental status]]
* [[Abdominal]]/[[flank]] [[mass]]
* [[Fever]]
* [[Weight loss]]
|
* ↑ [[ESR]]
* ↑ [[LDH]]
* ↑ [[Serum]] [[ACTH]]
* ↓ [[Hyponatremia]]
* Low early morning [[serum]] [[cortisol]] levels
* Low basal [[urinary]] [[cortisol]]
* ↓ [[Aldosterone]]
|
* [[Histopathology]] is gold standard
* Diffuse growth pattern with large [[cells]] ( 5× normal [[lymphocytes]]) resembling [[immunoblasts]]
* Extensive [[necrosis]]
* May resemble [[anaplastic]] large [[cell]] [[lymphoma]] or [[metastatic]] [[carcinoma]]
* Abundant [[T-cells]]
|
* Complete [[endocrine]] panel
* [[Ultrasound]]
* [[ACTH]] stimulation test
* [[CT]]-guided needle [[biopsy]]
* <sup>18</sup>F-fluorodeoxyglucose ([[FDG]]) [[positron emission tomography]] [[PET]]/[[CT]]
|
* Heterogeneous [[mass]]
* [[Hemorrhages]]
|
* Heterogeneous [[mass]]
* [[Hemorrhages]]
* [[Necrosis]]
|
* N/A
|
* Enlarged [[retroperitoneal]] [[lymph nodes]]
* Low intensity (T1)
* High intensity (T2)
|
* May stain positive for:
** [[CD3]], [[CD19]], [[CD20]], [[CD22]]
** [[BCL6]] / [[CD10]]
** [[CD43]], [[CD45]]
** [[Immunoglobulin A|Surface Ig]]
** [[CD68]]
** [[CD79a]]
** [[LCA]]
** [[Pax genes|Pax 5]]
|-
|-
| colspan="2" |Limb CM + congenital non-progressive limb overgrowth
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cystic Lymphangioma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid27011561">{{cite journal |vauthors=Michalopoulos N, Laskou S, Karayannopoulou G, Pavlidis L, Kanellos I |title=Adrenal Gland Lymphangiomas |journal=Indian J Surg |volume=77 |issue=Suppl 3 |pages=1334–42 |date=December 2015 |pmid=27011561 |pmc=4775622 |doi=10.1007/s12262-015-1206-y |url=}}</ref><ref name="pmid25197378">{{cite journal |vauthors=Zhao M, Gu Q, Li C, Yu J, Qi H |title=Cystic lymphangioma of adrenal gland: a clinicopathological study of 3 cases and review of literature |journal=Int J Clin Exp Pathol |volume=7 |issue=8 |pages=5051–6 |date=2014 |pmid=25197378 |pmc=4152068 |doi= |url=}}</ref><ref name="pmid25889625">{{cite journal |vauthors=Joliat GR, Melloul E, Djafarrian R, Schmidt S, Fontanella S, Yan P, Demartines N, Halkic N |title=Cystic lymphangioma of the adrenal gland: report of a case and review of the literature |journal=World J Surg Oncol |volume=13 |issue= |pages=58 |date=February 2015 |pmid=25889625 |pmc=4335415 |doi=10.1186/s12957-015-0490-0 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
|
* Asymptomatic
* [[Flank]]/back/[[abdominal]] [[pain]]
* [[Abdominal]]/[[flank]] [[mass]]
* [[GI]] obstruction
|
* N/L
* Palpable [[mass]]
* [[Hypertension]]
* [[Fever]]
|
* N/L
|
* [[Histopathology]] is gold standard
* Cystic channels and spaces
* Flat [[endothelial cells]]
* Mature [[lymphoid]] aggregates
|
* Complete [[endocrine]] panel
* [[Ultrasound]]
* [[FDG]]-[[PET]] scan
* [[Aspiration]] & [[biopsy]]
|
* Well-demarcated
* [[Calcification]]
|
* Well-demarcated
* Low-density
* [[Calcification]]
|
* N/A
|
* T1 hypointense & T2 hyperintense
|
|
* Associated with [[Gorlin-Goltz syndrome]]
* Stains positive for [[CD31]], [[CD34]], and D2-40 and negative for [[cytokeratin]]
|-
|-
| colspan="2" |Maffucci syndrome
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Teratoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid29067922">{{cite journal |vauthors=Ramakant P, Rana C, Singh KR, Mishra A |title=Primary adrenal teratoma: An unusual tumor - Challenges in diagnosis and surgical management |journal=J Postgrad Med |volume=64 |issue=2 |pages=112–114 |date=2018 |pmid=29067922 |pmc=5954807 |doi=10.4103/jpgm.JPGM_588_16 |url=}}</ref><ref name="pmid26722254">{{cite journal |vauthors=Li S, Li H, Ji Z, Yan W, Zhang Y |title=Primary adrenal teratoma: Clinical characteristics and retroperitoneal laparoscopic resection in five adults |journal=Oncol Lett |volume=10 |issue=5 |pages=2865–2870 |date=November 2015 |pmid=26722254 |pmc=4665718 |doi=10.3892/ol.2015.3701 |url=}}</ref><ref name="pmid30214733">{{cite journal |vauthors=Zhou L, Pan X, He T, Lai Y, Li W, Hu Y, Ni L, Yang S, Chen Y, Lai Y |title=Primary adrenal teratoma: A case series and review of the literature |journal=Mol Clin Oncol |volume=9 |issue=4 |pages=437–442 |date=October 2018 |pmid=30214733 |pmc=6125700 |doi=10.3892/mco.2018.1687 |url=}}</ref>
|VM +/-spindle-cell hemangioma + enchondroma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
|
* Asymptomatic
* [[Abdominal]]/back discomfort & [[pain]]
* [[Abdominal]] distension
* [[Lumbago]]
* [[Nausea]] & [[vomiting]]
* Local obstructive [[symptoms]]
|
* N/L
* [[Abdominal]] distension
* [[Abdominal]] [[mass]]
* [[Weight loss]]
* [[Urinary]] retention
* Lower extremity [[edema]]
* [[Peritoneal]] [[effusion]] or [[peritonitis]] (rupture)
|
* N/L
|
* [[Fibrous tissue]], [[adipose tissue]] and [[muscle fibers]]
* [[Stratified squamous epithelium]], [[hair]] shafts, [[fat cells]], [[GI]] and [[respiratory]] [[epithelium]]
* [[Necrosis]]
* [[Calcification]]
|
* Complete [[endocrine]] panel
* <sup>18</sup>F-fluorodeoxyglucose ([[FDG]]) [[positron emission tomography]] [[PET]]/[[CT]]
* Post-resection [[biopsy]] (if [[malignancy]] is suspected)
|
* Heterogeneous
* Mixed echo ([[Ultrasonogram|U/S]])
|
* Heterogeneous
* Mixed density elements
* Egg-shell [[calcification]]
* Mild enhancement
|
* N/A
|
* Mild enhancement
* Mixed signals ([[MRI]])
|
* Derived from [[germ layers]]
* Majority are [[benign]], but about one forth of [[adrenal]] [[teratoma]] are [[malignant]] [[lesions]]
|-
|-
| colspan="2" |Macrocephaly-CM (M-CM / MCAP) *
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Metastases]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid15541184">{{cite journal |vauthors=Karanikiotis C, Tentes AA, Markakidis S, Vafiadis K |title=Large bilateral adrenal metastases in non-small cell lung cancer |journal=World J Surg Oncol |volume=2 |issue= |pages=37 |date=November 2004 |pmid=15541184 |pmc=535544 |doi=10.1186/1477-7819-2-37 |url=}}</ref><ref name="pmid15405683">{{cite journal |vauthors=ABRAMS HL, SPIRO R, GOLDSTEIN N |title=Metastases in carcinoma; analysis of 1000 autopsied cases |journal=Cancer |volume=3 |issue=1 |pages=74–85 |date=January 1950 |pmid=15405683 |doi= |url=}}</ref><ref name="pmid15554272">{{cite journal |vauthors=Gerber E, Dinlenc C, Wagner JR |title=Laparoscopic adrenalectomy for isolated adrenal metastasis |journal=JSLS |volume=8 |issue=4 |pages=314–9 |date=2004 |pmid=15554272 |pmc=3016821 |doi= |url=}}</ref><ref name="pmid9781426">{{cite journal |vauthors=Vaughan ED |title=Diagnosis and management of surgical adrenal disorders |journal=Int. J. Urol. |volume=5 |issue=5 |pages=401–17 |date=September 1998 |pmid=9781426 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Related to the primary [[tumor]]
|
|
|-
* Asymptomatic
| colspan="2" |Microcephaly-CM (MICCAP)
* [[Adrenal insufficiency]]
* [[Abdominal]] [[mass]] & discomfort
* [[Symptoms]] due to primary [[tumor]] that may include:
** [[Lung cancer]]
** [[Breast cancer]]
** [[Gastric cancer]]
** [[Liver cancer]]
** [[Pancreatic cancer]]
** [[Renal cell carcinoma]]
** [[Melanoma]]
** [[Lymphoma]]
|
* Asymptomatic
* [[Adrenal insufficiency]]
* [[Abdominal]] [[mass]]
* [[Signs]] due to primary [[tumor]] that may include
** [[Lung cancer]]
** [[Breast cancer]]
** [[Gastric cancer]]
** [[Liver cancer]]
** [[Pancreatic cancer]]
** [[Renal cell carcinoma]]
** [[Melanoma]]
** [[Lymphoma]]
|
* Varies depending on the primary [[tumor]]
* N/L
* If [[adrenal insufficiency]]:
** [[Hyponatremia]]
** [[Hyperkalemia]]
** [[Hypoglycemia]]
** Low early morning [[serum]] [[cortisol]] levels
** Low basal [[urinary]] [[cortisol]]
** ↑ [[ACTH]]
** ↓ [[Aldosterone]]
** ↑ [[Plasma]] [[renin]]
|
* Single or multiple firm [[masses]]
* [[Hemorrhage]]
* [[Necrosis]]
 
* [[Morphology]] similar to the primary [[tumor]]
* Compression and [[atrophy]] of adjacent [[adrenal]] [[tissue]]
|
* [[Blood]] and [[urine]] lab testing
* Complete [[endocrine]] panel
* [[Imaging]] of [[chest]], [[abdomen]], and [[pelvis]]
* [[Immunohistochemistry]]
* [[Endoscopy]]
* [[MRCP]] & [[ERCP]]
* <sup>18</sup>F-fluorodeoxyglucose ([[FDG]]) [[positron emission tomography]] [[PET]]/[[CT]]
|
* [[Calcification]]
* [[Hemorrhage]]
|
* [[Calcification]]
* [[Hemorrhage]]
* Irregular peripheral enhancement
|
* N/A
|
* Low signal on T1-weighed [[MRI]] and high signal on T2-weighed [[MRI]]
OR
* Isointense on T1- and T2-weighed [[MRI]]
|
|
|-
* [[Metastases]] more common than primary [[adrenal tumors]]
| colspan="2" |CLOVES syndrome *
* [[Adrenal]] [[hemorrhage]] is the most serious [[complication]] and may present as [[adrenal crisis]] and/or [[shock]]
|LM + VM + CM +/-AVM+ lipomatous overgrowth
|-
| colspan="2" |Proteus syndrome
|CM, VM and/or LM + asymmetrical somatic overgrowth
|-
|Bannayan-Riley-Ruvalcaba sd
| colspan="2" |lower lip CM + face and neck LM + asymmetry and partial/generalized overgrowth
|}
|}
==Provisionally unclassified vascular anomalies==
===Intramuscular hemangioma===
* Characterized by benign proliferation of vascular channels. Majority of lesions occur in subcutaneous adipose tissues, followed by muscles. Thigh and calf are most common sites of occurrence. Majority of the lesions are asymptomatic. Typical clinical presentation includes chronic pain and swelling that both may increase with exercise of affected muscle due to increased blood flow. Other clinical manifestations may include pulsations, discoloration over the lesion, lesion enlargement when in dependent position, increased temperature, muscle contracture, tenderness, and muscle weakness and fatigue.<ref name="pmid24427416">{{cite journal |vauthors=Wierzbicki JM, Henderson JH, Scarborough MT, Bush CH, Reith JD, Clugston JR |title=Intramuscular hemangiomas |journal=Sports Health |volume=5 |issue=5 |pages=448–54 |date=September 2013 |pmid=24427416 |pmc=3752185 |doi=10.1177/1941738112470910 |url=}}</ref><ref name="pmid15155443">{{cite journal |vauthors=Brown RA, Crichton K, Malouf GM |title=Intramuscular haemangioma of the thigh in a basketball player |journal=Br J Sports Med |volume=38 |issue=3 |pages=346–8 |date=June 2004 |pmid=15155443 |pmc=1724833 |doi= |url=}}</ref>
* Intramuscular hemangiomas may be associated with Kasabach-Merritt syndrome characterized by thrombocytopenia and/or consumptive coagulopathy. This lesion may also lead to functional impairment, congestive cardiac failure due to AV shunting, pressure symptoms, skin necrosis and may also erode bone.<ref name="pmid15155443"></ref><ref name="pmid28507959">{{cite journal |vauthors=Patnaik S, Kumar P, Nayak B, Mohapatra N |title=Intramuscular Arteriovenous Hemangioma of Thigh: A Case Report and Review of Literature |journal=J Orthop Case Rep |volume=6 |issue=5 |pages=20–23 |date=2016 |pmid=28507959 |pmc=5404154 |doi=10.13107/jocr.2250-0685.612 |url=}}</ref>
* Etiology and pathophysiology are not clearly defined but majority of the lesions are congenital while a one fifth may be associated with trauma.<ref name="pmid24427416"></ref>
* MRI is the diagnostic study of choice although X-RAY and ultrasound may be used as initial studies. Treatment is generally not indicated for asymptomatic lesions. Management options for symptomatic, complicated and for cosmetic reasons may include laser ablation, systemic corticosteroids, cryotherapy, embolization, radiation, compression sclerotherapy, and surgical excision although surgical excision is usually treatment of choice in majority of the cases.<ref name="pmid24427416"></ref><ref name="pmid15155443"></ref><ref name="pmid28507959"></ref><ref name="pmid12011711">{{cite journal |vauthors=Tang P, Hornicek FJ, Gebhardt MC, Cates J, Mankin HJ |title=Surgical treatment of hemangiomas of soft tissue |journal=Clin. Orthop. Relat. Res. |volume= |issue=399 |pages=205–10 |date=June 2002 |pmid=12011711 |doi= |url=}}</ref><ref name="pmid17596677">{{cite journal |vauthors=Kim DH, Hwang M, Kang YK, Kim IJ, Park YK |title=Intramuscular hemangioma mimicking myofascial pain syndrome: a case report |journal=J. Korean Med. Sci. |volume=22 |issue=3 |pages=580–2 |date=June 2007 |pmid=17596677 |pmc=2693661 |doi=10.3346/jkms.2007.22.3.580 |url=}}</ref><ref name="pmid25198963">{{cite journal |vauthors=Babu D, Bhamre R, Katna R, Pai P |title=Intramuscular haemangioma of the tongue |journal=Ann R Coll Surg Engl |volume=96 |issue=6 |pages=e15–7 |date=September 2014 |pmid=25198963 |pmc=4474220 |doi=10.1308/003588414X13946184903126 |url=}}</ref>
===Angiokeratoma===
* A muco-cutaneous vascular lesion with wart-like papular appearance characterized by dilated capillaries in the dermis and hyperkeratotis of the overlying epidermis. Clinically it may manifest as solitary or multiple hyperkeratotic papules that may be localized or generalized, most typically on scrotum, thighs, lower extremity, abdomen, trunk, tongue, penis and labia majora. Majority of the lesions are asymptomatic but some may ulcerate and/or bleed.<ref name="pmid25100920">{{cite journal |vauthors=Hussein RS, Kfoury H, Al-Faky YH |title=Eyelid angiokeratoma |journal=Middle East Afr J Ophthalmol |volume=21 |issue=3 |pages=287–8 |date=2014 |pmid=25100920 |pmc=4123288 |doi=10.4103/0974-9233.134702 |url=}}</ref><ref name="pmid16988295">{{cite journal |vauthors=Trickett R, Dowd H |title=Angiokeratoma of the scrotum: a case of scrotal bleeding |journal=Emerg Med J |volume=23 |issue=10 |pages=e57 |date=October 2006 |pmid=16988295 |pmc=2579622 |doi=10.1136/emj.2006.038745 |url=}}</ref>
* It may be classified into following entities:<ref name="pmid26155544">{{cite journal |vauthors=Chowdappa V, Narasimha A, Bhat A, Masamatti SS |title=Solitary Angiokeratoma: Report of Two Uncommon Cases |journal=J Clin Diagn Res |volume=9 |issue=5 |pages=WD01–2 |date=May 2015 |pmid=26155544 |pmc=4484136 |doi=10.7860/JCDR/2015/12163.5946 |url=}}</ref>
** Fordyce’s angiokeratoma (arising on the genitals)
** Mibelli’s angiokeratoma (dorsum of toes and fingers)
** Angiokeratoma circumscriptum naeviforme (unilateral large keratotic plaques)
** Angiokeratoma corporis diffusum (ACD) (generalized lesions between umbilicus and the knee)
* Angiokeratomas are more prevalent among males as compared to females. Increased venous pressure and radiation therapy have been cited as possible causes. Angiokeratomas have been associated with enzyme deficiencies such as  alpha-galactosidase A (Fabry disease), α-fucosidase (fucosidosis), neuraminidase (sialodosis), aspartyl glycosaminase (aspartyl glucosaminuria), β-mannosidase (β- mannosidosis), α-N-acetyl galactosaminidase (Kansaki disease), and β-galactosidase (adult onset GM1 gangliosidosis).<ref name="pmid25100920"></ref><ref name="pmid16988295"></ref><ref name="pmid26155544">{{cite journal |vauthors=Chowdappa V, Narasimha A, Bhat A, Masamatti SS |title=Solitary Angiokeratoma: Report of Two Uncommon Cases |journal=J Clin Diagn Res |volume=9 |issue=5 |pages=WD01–2 |date=May 2015 |pmid=26155544 |pmc=4484136 |doi=10.7860/JCDR/2015/12163.5946 |url=}}</ref><ref name="pmid19468654">{{cite journal |vauthors=Rees R, Freeman A, Malone P, Garaffa G, Muneer A, Minhas S |title=Case study: the surgical management of angiokeratoma resulting from radiotherapy for penile cancer |journal=ScientificWorldJournal |volume=9 |issue= |pages=339–42 |date=May 2009 |pmid=19468654 |pmc=5823195 |doi=10.1100/tsw.2009.23 |url=}}</ref>
* The diagnosis is mainly clinical but biopsy may be required. Associated enzyme deficiencies and systemic disorders must be ruled out. Treatment is generally not indicated but if so required then excision, electrocautery, cryotherapy, or laser ablations are the options.<ref name="pmid25100920"></ref><ref name="pmid19468654"></ref><ref name="pmid26155544"></ref><ref name="pmid29644211">{{cite journal |vauthors=Jha AK, Sonthalia S, Jakhar D |title=Dermoscopy of Angiokeratoma |journal=Indian Dermatol Online J |volume=9 |issue=2 |pages=141–142 |date=2018 |pmid=29644211 |pmc=5885630 |doi=10.4103/idoj.IDOJ_278_17 |url=}}</ref>
===Sinusoidal hemangioma===
* A variant of cavernous hemangioma characterized histopathologically by presence of dilated thin-walled vascular channels, that vary in size, exhibiting nodular proliferation with sinusoidal arrangement.  Pseudopapillary structures may also be present. Clinically majority of the lesions manifest in female adults as single, well-defined, painless, subcutaneous nodule with bluish color. Most frequent locations are trunk, extremities and breasts. Painless swelling is the most common patient complaint.<ref name="pmid22148063">{{cite journal |vauthors=Song BH, Youn SH, Park EJ, Kwon IH, Kim KH, Kim KJ |title=A case of sinusoidal hemangioma with lipoma |journal=Ann Dermatol |volume=23 |issue=Suppl 2 |pages=S250–3 |date=October 2011 |pmid=22148063 |pmc=3229078 |doi=10.5021/ad.2011.23.S2.S250 |url=}}</ref><ref name="pmid21892538">{{cite journal |vauthors=Ciurea M, Ciurea R, Popa D, Pârvănescu H, Marinescu D, Vrabete M |title=Sinusoidal hemangioma of the arm: case report and review of literature |journal=Rom J Morphol Embryol |volume=52 |issue=3 |pages=915–8 |date=2011 |pmid=21892538 |doi= |url=}}</ref><ref name="pmid26729822">{{cite journal |vauthors=Konda P, Bavle RM, Makarla S, Muniswamappa S |title=Intramuscular sinusoidal haemangioma with secondary Masson's phenomenon |journal=BMJ Case Rep |volume=2016 |issue= |pages= |date=January 2016 |pmid=26729822 |pmc=4716435 |doi=10.1136/bcr-2013-201457 |url=}}</ref>
* Abnormalities of vasculogenesis and angiogenesis have been proposed as pathogenesis but it is not well-established.<ref name="pmid21892538"></ref>
* Combination of clinical manifestations and histopathological features is used for diagnosis. Surgery (wide excision of tumor) is the treatment of choice if treatment is required.<ref name="pmid21892538"></ref><ref name="pmid26729822"></ref><ref name="pmid28210560">{{cite journal |vauthors=Salemis NS |title=Sinusoidal hemangioma of the breast: diagnostic evaluation management and literature review |journal=Gland Surg |volume=6 |issue=1 |pages=105–109 |date=February 2017 |pmid=28210560 |pmc=5293651 |doi=10.21037/gs.2016.11.06 |url=}}</ref>
===Acral arteriovenous "tumour"===
* Congenital or acquired lesion manifesting clinically as asymptomatic mass or may present with pulsatile swelling, headache, localized throbbing pain, tinnitus and bleeding. Histopathologically they are characterized by arterio-venous connection without connecting capillary with or without intracranial component. The lesion derived its name from its acral distribution.<ref name="pmid25624933">{{cite journal |vauthors=Gupta R, Kayal A |title=Scalp arteriovenous malformations in young |journal=J Pediatr Neurosci |volume=9 |issue=3 |pages=263–6 |date=2014 |pmid=25624933 |pmc=4302550 |doi=10.4103/1817-1745.147587 |url=}}</ref><ref name="pmid29492122">{{cite journal |vauthors=Özkara E, Özbek Z, Özdemir AÖ, Arslantaş A |title=Misdiagnosed Case of Scalp Arteriovenous Malformation |journal=Asian J Neurosurg |volume=13 |issue=1 |pages=59–61 |date=2018 |pmid=29492122 |pmc=5820896 |doi=10.4103/1793-5482.181137 |url=}}</ref>
* Etiology can be classified as following: Congenital, traumatic, infection and inflammation and familial.<ref name="pmid25624933"></ref><ref name="pmid4682507">{{cite journal |vauthors=Khodadad G |title=Arteriovenous malformations of the scalp |journal=Ann. Surg. |volume=177 |issue=1 |pages=79–85 |date=January 1973 |pmid=4682507 |pmc=1355509 |doi= |url=}}</ref>
* Although diagnosis can be made clinically, angiography is the gold standard diagnostic modality to diagnose and define the extent of the lesion. Management regimen may include surgical excision, ligation of the supplying arteries, embolization, and intralesional sclerosing injection.<ref name="pmid29492122"></ref><ref name="pmid23960313">{{cite journal |vauthors=Chowdhury FH, Haque MR, Kawsar KA, Sarker MH, Momtazul Haque AF |title=Surgical management of scalp arterio-venous malformation and scalp venous malformation: An experience of eleven cases |journal=Indian J Plast Surg |volume=46 |issue=1 |pages=98–107 |date=January 2013 |pmid=23960313 |pmc=3745130 |doi=10.4103/0970-0358.113723 |url=}}</ref><ref name="pmid23559986">{{cite journal |vauthors=El Shazly AA, Saoud KM |title=Results of surgical excision of cirsoid aneurysm of the scalp without preoperative interventions |journal=Asian J Neurosurg |volume=7 |issue=4 |pages=191–6 |date=October 2012 |pmid=23559986 |pmc=3613641 |doi=10.4103/1793-5482.106651 |url=}}</ref><ref name="pmid1271098">{{cite journal |vauthors=Kasdon DL, Altemus LR, Stein BM |title=Embolization of a traumatic arteriovenous fistula of the scalp with radiopaque Gelfoam pledgets. Case report and technical note |journal=J. Neurosurg. |volume=44 |issue=6 |pages=753–6 |date=June 1976 |pmid=1271098 |doi=10.3171/jns.1976.44.6.0753 |url=}}</ref><ref name="pmid8956889">{{cite journal |vauthors=Hendrix LE, Meyer GA, Erickson SJ |title=Cirsoid aneurysm treatment by percutaneous injection of sodium tetradecyl sulfate |journal=Surg Neurol |volume=46 |issue=6 |pages=557–60; discussion 560–1 |date=December 1996 |pmid=8956889 |doi= |url=}}</ref>
===Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral angiomatosis with thrombocytopenia (MLT/CAT)===
* Rare congenital disorder characterized by proliferation of vascular channels in multiple organs associated with thrombocytopenia of variable degree. Lesions may manifest themselves on skin, gastrointestinal tract, lungs, brain, bone, liver, spleen and muscles. Majority of cutaneous lesions present as multiple red to blue papules, plaques, nodules on trunk and extremities. Gastrointestinal bleeding due to multiple hemorrhagic lesions is the cause of mortality in majority of the patients. Similar lesions in brain and lungs may cause severe cerebral edema and pulmonary hemorrhage.<ref name="pmid26148948">{{cite journal |vauthors=Droitcourt C, Boccara O, Fraitag S, Favrais G, Dupuy A, Maruani A |title=Multifocal Lymphangioendotheliomatosis With Thrombocytopenia: Clinical Features and Response to Sirolimus |journal=Pediatrics |volume=136 |issue=2 |pages=e517–22 |date=August 2015 |pmid=26148948 |doi=10.1542/peds.2014-2410 |url=}}</ref><ref name="pmid25088066">{{cite journal |vauthors=Uller W, Kozakewich HP, Trenor CC, O'Hare M, Alomari AI |title=Cutaneovisceral angiomatosis with thrombocytopenia without cutaneous involvement |journal=J. Pediatr. |volume=165 |issue=4 |pages=876–876.e1 |date=October 2014 |pmid=25088066 |doi=10.1016/j.jpeds.2014.06.042 |url=}}</ref>
* Disease may manifest without cutaneous involvement or thrombocytopenia. Biopsy typically reveals proliferation of well differentiated vascular channels with intravascular papillary structure and thrombi, sometimes with hobnail appearance of lining endothelial cells.<ref name="pmid26148948"></ref><ref name="pmid22565464">{{cite journal |vauthors=Zegpi MS, Zavala A, del Puerto C, Cárdenas C, González S |title=Newborn with multifocal lymphangioendotheliomatosis with thrombocytopenia |journal=Indian J Dermatol Venereol Leprol |volume=78 |issue=3 |pages=409 |date=2012 |pmid=22565464 |doi=10.4103/0378-6323.95494 |url=}}</ref>
* Biopsy followed by histopathological and immunohistochemical are required for diagnosis. Management is not well-established and disorder has a poor prognosis with high mortality. Recently sirolimus and bevacizumab have been used to treat this diorder with some success.<ref name="pmid26148948"></ref><ref name="pmid22074937">{{cite journal |vauthors=Takahashi H, Nagatoshi Y, Kato M, Koh K, Kishimoto H, Kawai M, Fukuzawa R, Hanada R |title=Multifocal skin lesions and melena with thrombocytopenia in an infant |journal=J. Pediatr. |volume=160 |issue=3 |pages=524–524.e1 |date=March 2012 |pmid=22074937 |doi=10.1016/j.jpeds.2011.09.034 |url=}}</ref><ref name="pmid19101995">{{cite journal |vauthors=Kline RM, Buck LM |title=Bevacizumab treatment in multifocal lymphangioendotheliomatosis with thrombocytopenia |journal=Pediatr Blood Cancer |volume=52 |issue=4 |pages=534–6 |date=April 2009 |pmid=19101995 |doi=10.1002/pbc.21860 |url=}}</ref>
===Fibro adipose vascular anomaly (FAVA)===
* Vascular disorder typically manifesting as infiltration of muscles by fibrofatty tissues, atypical venodilation associated with localized pain, and contracture of the affected muscles. Majority of the lesions involve calf muscles and may present as painful mass, contracture of the extremity, and decreased dorsiflexion at ankle joint. Skin is not typically involved. Histological studies demonstrates fibrous and adipose tissue and congregations of venous channels with abnormal lymphatic component.<ref name="pmid25298836">{{cite journal |vauthors=Fernandez-Pineda I, Marcilla D, Downey-Carmona FJ, Roldan S, Ortega-Laureano L, Bernabeu-Wittel J |title=Lower Extremity Fibro-Adipose Vascular Anomaly (FAVA): A New Case of a Newly Delineated Disorder |journal=Ann Vasc Dis |volume=7 |issue=3 |pages=316–9 |date=2014 |pmid=25298836 |pmc=4180696 |doi=10.3400/avd.cr.14-00049 |url=}}</ref><ref name="pmid24322574">{{cite journal |vauthors=Alomari AI, Spencer SA, Arnold RW, Chaudry G, Kasser JR, Burrows PE, Govender P, Padua HM, Dillon B, Upton J, Taghinia AH, Fishman SJ, Mulliken JB, Fevurly RD, Greene AK, Landrigan-Ossar M, Paltiel HJ, Trenor CC, Kozakewich HP |title=Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity |journal=J Pediatr Orthop |volume=34 |issue=1 |pages=109–17 |date=January 2014 |pmid=24322574 |doi=10.1097/BPO.0b013e3182a1f0b8 |url=}}</ref>
* Somatic activating mutations in PIK3CA that encodes phosphatidylinositol 3-kinase (PI3K), an enzyme functioning in cell growth, proliferation, differentiation, and survival.<ref name="pmid25681199">{{cite journal |vauthors=Luks VL, Kamitaki N, Vivero MP, Uller W, Rab R, Bovée JV, Rialon KL, Guevara CJ, Alomari AI, Greene AK, Fishman SJ, Kozakewich HP, Maclellan RA, Mulliken JB, Rahbar R, Spencer SA, Trenor CC, Upton J, Zurakowski D, Perkins JA, Kirsh A, Bennett JT, Dobyns WB, Kurek KC, Warman ML, McCarroll SA, Murillo R |title=Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA |journal=J. Pediatr. |volume=166 |issue=4 |pages=1048–54.e1–5 |date=April 2015 |pmid=25681199 |pmc=4498659 |doi=10.1016/j.jpeds.2014.12.069 |url=}}</ref>
* Clinical and radiological findings are often sufficient to form the diagnosis. Inconclusive cases my require biopsy. Surgical resection is the often the preferred treatment and is more effective than sclerotherapy, the alternative therapy.<ref name="pmid25298836"></ref><ref name="pmid24322574"></ref>
==Vascular malformations associated with other anomalies==
===Klippel-Trenaunay syndrome===
* First described by Klippel and Trenaunay in 1900, this congeital syndrome is characterized by presence of capillary malformations, venous malformations, and soft tissues and bone hypertrophy. Lymphatic malformations may or may not be present. Capillary malformations typically present in form of capillary hemangioma and can occur anywhere on the body while venous and lymphatic malformations, and soft tissue and bone hypertrophy usually involves the extremities.<ref name="pmid28458832">{{cite journal |vauthors=Baba A, Yamazoe S, Okuyama Y, Shimizu K, Kobashi Y, Nozawa Y, Munetomo Y, Mogami T |title=A rare presentation of Klippel-Trenaunay syndrome with bilateral lower limbs |journal=J Surg Case Rep |volume=2017 |issue=2 |pages=rjx024 |date=February 2017 |pmid=28458832 |pmc=5400491 |doi=10.1093/jscr/rjx024 |url=}}</ref><ref name="pmid27921060">{{cite journal |vauthors=Tetangco EP, Arshad HM, Silva R |title=Klippel-Trenaunay Syndrome of the Rectosigmoid Colon Presenting as Severe Anemia |journal=ACG Case Rep J |volume=3 |issue=4 |pages=e161 |date=August 2016 |pmid=27921060 |pmc=5126491 |doi=10.14309/crj.2016.134 |url=}}</ref>
* Clinical manifestations are unilateral in 85% of the cases and may include localized pain and discomfort, leg length discrepancy due to hemihypertrophy, developmental delay, limb abnormalities such as polydactyly, macrodactyly, syndactyly, thrombophlebitis, osteomyelitis, pathological fractures, heart failure, , erysipelas, venous thrombosis due to malformations, pulmonary embolism, gastrointestinal bleeding due to venous overload in the internal iliac vein and ophthalmic abnormalities such as telangiectasia, orbital varix, strabismus, oculosympathetic palsy, Marcus-Gunn pupil, iris coloboma and heterochromia, cataracts, persistent fetal vasculature, varicosities.<ref name="pmid28458832"></ref><ref name="pmid27921060"></ref><ref name="pmid29930667">{{cite journal |vauthors=Chagas CAA, Pires LAS, Babinski MA, Leite TFO |title=Klippel-Trenaunay and Parkes-Weber syndromes: two case reports |journal=J Vasc Bras |volume=16 |issue=4 |pages=320–324 |date=2017 |pmid=29930667 |pmc=5944310 |doi=10.1590/1677-5449.005417 |url=}}</ref>
* Etiology and pathogenesis have not been established yet. Some suggestions include PIK3CA mutations, polygenic inheritance, VG5Q mutation and obstruction of the venous system.<ref name="pmid28458832"></ref><ref name="pmid29930667"></ref><ref name="urlwww.issva.org">{{cite web |url=http://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf |title=www.issva.org |format= |work= |accessdate=}}</ref>
* Diagnosis can be made on clinical manifestations and can be confirmed by Doppler ultrasound and magnetic resonance angiography. Management depends on clinical manifestations.<ref name="pmid28458832"></ref><ref name="pmid29930667"></ref><ref name="pmid29452831">{{cite journal |vauthors=Lei H, Guan X, Han H, Qian X, Zhou X, Zhang X, Tian L |title=Painless Urethral Bleeding During Penile Erection in an Adult Man With Klippel-Trenaunay Syndrome: A Case Report |journal=Sex Med |volume=6 |issue=2 |pages=180–183 |date=June 2018 |pmid=29452831 |pmc=5960021 |doi=10.1016/j.esxm.2017.12.001 |url=}}</ref>
===Parkes Weber syndrome===
*  Characterized by a cutaneous flush with underlying multiple micro-AVFs (arteriovenous fistulas), in association with soft tissue and skeletal hypertrophy of the affected limb. Clinical Presentation enlarged arteries and veins, capillary or venous malformations, cutaneous blush, arteriovenous fistulas, and enlargement of limb.
* Mutation in the RASA1 gene has been found to be associated with this syndrome.
* To learn more about Parkes Weber syndrome, click here.
===Servelle-Martorell syndrome===
* Also called phlebectatic osteohypoplastic angiodysplasia, this rare syndrome is characterized by venous malformations such as abnormal location of vein, partial or complete absence of valves, and/or venous hypoplasia or aplasia and undergrowth of bone. These abnormalities may also be associated with limb hypertrophy and arterial malformations.<ref name="pmid18454870">{{cite journal |vauthors=Karuppal R, Raman RV, Valsalan BP, Gopakumar Ts, Kumaran CM, Vasu CK |title=Servelle-Martorell syndrome with extensive upper limb involvement: a case report |journal=J Med Case Rep |volume=2 |issue= |pages=142 |date=May 2008 |pmid=18454870 |pmc=2394530 |doi=10.1186/1752-1947-2-142 |url=}}</ref>
* Clinical manifestations may include cutaneous compressible lesions due to malformations, cellulitis, lesion limb shortening, joint and soft tissue pain and swelling, tortuous limbs, reduced muscle mass, venous thrombosis, consumption coagulopathy, pathological fractures and bone tenderness.<ref name="pmid18454870"></ref><ref name="pmid10683361">{{cite journal |vauthors=Weiss T, Mädler U, Oberwittler H, Kahle B, Weiss C, Kübler W |title=Peripheral vascular malformation (Servelle-Martorell) |journal=Circulation |volume=101 |issue=7 |pages=E82–3 |date=February 2000 |pmid=10683361 |doi= |url=}}</ref>
* Combination of clinical and radiological findings is used to form the  diagnosis, MRI can assess the involvement and extent of lesions. Treatment is mainly conservative with surgery being used in some cases to excise and/or correct malformations.<ref name="pmid18454870"></ref>
===Sturge-Weber syndrome===
* Congenital syndrome characterized by capillary malformations involving face and laptomeninges and eye abnormalities. There may also be bone and/or overgrowth.<ref name="urlwww.issva.org">{{cite web |url=+http://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf |title=www.issva.org |format= |work= |accessdate=}}</ref>
* Clinical manifestations may include seizures, port-wine stain on the forehead and upper eyelid of one side of the face,  muscle weakness, developmental delays and mental retardation, glaucoma, and buphthalmos.
* Associated with mutations in GNAQ gene that encodes for members of G protein family.
* To learn more about Sturge-Weber syndrome, click here.
===Maffucci syndrome===
* A rare disorder characterized by presence of venous malformations associated with multiple enchondromas, benign cartilage-forming tumors, and multiple soft tissues hemangiomas and lymphangiomas. These benign tumors have tendency to undergo malignant transformation in maffuci syndrome. People with maffuci syndrome are also at increased risk of developing other malignant tumors such as glioma, glioblastoma, acute myeloid leukemia, intrahepatic cholangiocarcinomas, hepatocellular carcinoma, pancreatic, and breast malignancies. Clinical manifestations depend on the coexixting lesions.<ref name="pmid26920730">{{cite journal |vauthors=Prokopchuk O, Andres S, Becker K, Holzapfel K, Hartmann D, Friess H |title=Maffucci syndrome and neoplasms: a case report and review of the literature |journal=BMC Res Notes |volume=9 |issue= |pages=126 |date=February 2016 |pmid=26920730 |pmc=4769492 |doi=10.1186/s13104-016-1913-x |url=}}</ref><ref name="pmid24344754">{{cite journal |vauthors=Moriya K, Kaneko MK, Liu X, Hosaka M, Fujishima F, Sakuma J, Ogasawara S, Watanabe M, Sasahara Y, Kure S, Kato Y |title=IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome |journal=Cancer Sci. |volume=105 |issue=3 |pages=359–62 |date=March 2014 |pmid=24344754 |pmc=4317937 |doi=10.1111/cas.12337 |url=}}</ref><ref name="pmid22147000">{{cite journal |vauthors=Verdegaal SH, Bovée JV, Pansuriya TC, Grimer RJ, Ozger H, Jutte PC, San Julian M, Biau DJ, van der Geest IC, Leithner A, Streitbürger A, Klenke FM, Gouin FG, Campanacci DA, Marec-Berard P, Hogendoorn PC, Brand R, Taminiau AH |title=Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients |journal=Oncologist |volume=16 |issue=12 |pages=1771–9 |date=2011 |pmid=22147000 |pmc=3248776 |doi=10.1634/theoncologist.2011-0200 |url=}}</ref>
* Mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2), enzymes involved in metabolism of isocitrate and α-ketoglutarate, and TP53, a cell-cycle regulator, have been found in tumors in maffuci syndrome.<ref name="pmid24344754"></ref><ref name="pmid22180306">{{cite journal |vauthors=Borger DR, Tanabe KK, Fan KC, Lopez HU, Fantin VR, Straley KS, Schenkein DP, Hezel AF, Ancukiewicz M, Liebman HM, Kwak EL, Clark JW, Ryan DP, Deshpande V, Dias-Santagata D, Ellisen LW, Zhu AX, Iafrate AJ |title=Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping |journal=Oncologist |volume=17 |issue=1 |pages=72–9 |date=2012 |pmid=22180306 |pmc=3267826 |doi=10.1634/theoncologist.2011-0386 |url=}}</ref><ref name="pmid25043045">{{cite journal |vauthors=Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, Akbay EA, Sia D, Cornella H, Miltiadous O, Walesky C, Deshpande V, Zhu AX, Hezel AF, Yen KE, Straley KS, Travins J, Popovici-Muller J, Gliser C, Ferrone CR, Apte U, Llovet JM, Wong KK, Ramaswamy S, Bardeesy N |title=Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer |journal=Nature |volume=513 |issue=7516 |pages=110–4 |date=September 2014 |pmid=25043045 |pmc=4499230 |doi=10.1038/nature13441 |url=}}</ref>
* Patients should be evaluated to check for malignant transformation. Some recommend CT scans and PET scans at regular intervals.<ref name="pmid26920730"></ref><ref name="pmid25537758">{{cite journal |vauthors=Al-Katib S, Al-Faham Z, Grant P, Palka JC |title=The Appearance of Maffucci Syndrome on 18F-FDG PET/CT |journal=J Nucl Med Technol |volume=43 |issue=2 |pages=131–2 |date=June 2015 |pmid=25537758 |doi=10.2967/jnmt.114.146480 |url=}}</ref>
* To learn more about maffuci syndrome, click here.
===CLOVES syndrome===
* CLOVES is an acronym for congenital lipomatous overgrowth, vascular malformations, epidermal nevi, skeletal and spinal anomalies. Vascular malformations in this syndrome include venous, capillary and lymphatic malformations with or without combined arteriovenous malformations. Pulmonary thromboembolism and respiratory failure are the cause of mortality in majority of the patients. Lipomatous and vascular abnormalities are often segmental and asymmetric in distribution and present typically on chest and abdominal wall.<ref name="urlwww.issva.org">{{cite web |url=http://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf |title=www.issva.org |format= |work= |accessdate=}}</ref><ref name="pmid25044986">{{cite journal |vauthors=Emrick LT, Murphy L, Shamshirsaz AA, Ruano R, Cassady CI, Liu L, Chang F, Sutton VR, Li M, Van den Veyver IB |title=Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes |journal=Am. J. Med. Genet. A |volume=164A |issue=10 |pages=2633–7 |date=October 2014 |pmid=25044986 |pmc=4496426 |doi=10.1002/ajmg.a.36672 |url=}}</ref><ref name="pmid25709171">{{cite journal |vauthors=Gopal B, Keshava SN, Selvaraj D |title=A rare newly described overgrowth syndrome with vascular malformations-Cloves syndrome |journal=Indian J Radiol Imaging |volume=25 |issue=1 |pages=71–3 |date=2015 |pmid=25709171 |pmc=4329693 |doi=10.4103/0971-3026.150166 |url=}}</ref>
* Clinical and imaging findings may include swellings due to lipomatous growths, skin discoloration, port wine stain bilateral epidermal nevi,leg length discrepancy,  developmental limb anomalies such as increased gap between the first and second toes, hemorrhage, seizures, ascites, pleural effusions, hypotension, bilateral multicystic venous lymphatic malformations, chest wall venous dilatation, multiple congenital hemangiomas, asymmetric septal hypertrophy, renal hypoplasia, dislocated knees, scoliosis, and neural tube defect.<ref name="pmid25044986"></ref><ref name="pmid25709171"></ref><ref name="pmid25400966">{{cite journal |vauthors=Sarici D, Akin MA, Kurtoglu S, Tubas F, Sarici SU |title=A Neonate with CLOVES Syndrome |journal=Case Rep Pediatr |volume=2014 |issue= |pages=845074 |date=2014 |pmid=25400966 |pmc=4221976 |doi=10.1155/2014/845074 |url=}}</ref>
* Activating mutations in PICK3CA gene that encodes part of PI3K has been thought to be associated with this syndrome. These mutations may help enable the cells to grow independent of growth factors.<ref name="pmid25044986"></ref><ref name="pmid22658544">{{cite journal |vauthors=Kurek KC, Luks VL, Ayturk UM, Alomari AI, Fishman SJ, Spencer SA, Mulliken JB, Bowen ME, Yamamoto GL, Kozakewich HP, Warman ML |title=Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome |journal=Am. J. Hum. Genet. |volume=90 |issue=6 |pages=1108–15 |date=June 2012 |pmid=22658544 |pmc=3370283 |doi=10.1016/j.ajhg.2012.05.006 |url=}}</ref>
* This syndrome can be detected prenatally and its manifestations have been identified on prenatal ultrasound and fetal MRI. Treatment options include supportive management, surgical debulking and scletherapy but treatment is often complicated by severity of the disease resulting in anemia, coagulopathy and poor wound healing.<ref name="pmid25044986"></ref><ref name="pmid25400966"></ref>
===Proteus syndrome===
* Congenital syndrome characterized by asymmetric overgrowth of multiple tissues in limbs, hamartomas and vascular lesions such as capillary malformations, venous malformations, lymphatic malformations. Cerebriform connective tissue nevi, a pathognomonic lesion if present alone, are helpful in diagnosing Proteus syndrome. It may affect multiple organs such as eyes, spleen, liver, thymus, intestine, and lungs, and may cause facial dysmorphia. Some benign and malignant neoplasms such as testicular papillary adenocarcinoma and mesothelioma.<ref name="pmid29166516">{{cite journal |vauthors=Rocha RCC, Estrella MPS, Amaral DMD, Barbosa AM, Abreu MAMM |title=Proteus syndrome |journal=An Bras Dermatol |volume=92 |issue=5 |pages=717–720 |date=2017 |pmid=29166516 |pmc=5674710 |doi=10.1590/abd1806-4841.20174496 |url=}}</ref><ref name="pmid28377973">{{cite journal |vauthors=El-Sobky TA, Elsayed SM, El Mikkawy DM |title=Orthopaedic manifestations of Proteus syndrome in a child with literature update |journal=Bone Rep |volume=3 |issue= |pages=104–108 |date=December 2015 |pmid=28377973 |pmc=5365241 |doi=10.1016/j.bonr.2015.09.004 |url=}}</ref><ref name="pmid24882963">{{cite journal |vauthors=Sarman ZS, Yuksel N, Sarman H, Bayramgurler D |title=Proteus syndrome: report of a case with developmental glaucoma |journal=Korean J Ophthalmol |volume=28 |issue=3 |pages=272–4 |date=June 2014 |pmid=24882963 |pmc=4038735 |doi=10.3341/kjo.2014.28.3.272 |url=}}</ref><ref name="pmid25713623">{{cite journal |vauthors=Popescu MD, Burnei G, Draghici L, Draghici I |title=Proteus Syndrome: a difficult diagnosis and management plan |journal=J Med Life |volume=7 |issue=4 |pages=563–6 |date=2014 |pmid=25713623 |pmc=4316140 |doi= |url=}}</ref>
* Clinical manifestations and findings may include hemihypertrophy, asymmetry of the limbs, scoliosis, subcutaneous tumors, soft tissues tumors such as lipoma, limb abnormalities such as macrodactyly, hyperpigmented lesions on skin, verrucous epidermal nevi, lung diseases, pulmonary embolism, venous thrombosis,  glaucoma, strabismus, nystagmus, pseudopapileudema, cardiac defects such as ARVC, healed myocardial infarctions, cardiomyopathies, cardiac lipomas, and central nervous system findings. These findings may be detected prenatally or at birth but majority of the patients present after 6 months of birth.<ref name="pmid29166516"></ref><ref name="pmid28377973"></ref><ref name="pmid24882963"></ref><ref name="pmid25377688"></ref><ref name="pmid23896365">{{cite journal |vauthors=Trivedi D, Lee SY, Brundler MA, Parulekar MV |title=Fibrous tumor of the superior oblique tendon in Proteus syndrome |journal=J AAPOS |volume=17 |issue=4 |pages=420–2 |date=August 2013 |pmid=23896365 |doi=10.1016/j.jaapos.2013.03.019 |url=}}</ref><ref name="pmid2729359">{{cite journal |vauthors=Mayatepek E, Kurczynski TW, Ruppert ES, Hennessy JR, Brinker RA, French BN |title=Expanding the phenotype of the Proteus syndrome: a severely affected patient with new findings |journal=Am. J. Med. Genet. |volume=32 |issue=3 |pages=402–6 |date=March 1989 |pmid=2729359 |doi=10.1002/ajmg.1320320327 |url=}}</ref>
* Somatic mutations in AKT1 gene that encodes proteins functioning in AKT/PI3K signaling pathway has been proposed to be the cause of this syndrome. This pathway functions in cell growth, differentiation and survival.<ref name="pmid25377688"></ref><ref name="pmid22876373">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Biesecker LG, Sapp JC |title= |journal= |volume= |issue= |pages= |date= |pmid=22876373 |doi= |url=}}</ref>
* Diagnosis is based on clinical and radiological findings and must meet general and specific criteria. Management consists of clinical and psychological assistance. This may include orthopedic consultation to stop or delay bone growth, physical rehabilitation, surgical correction of deformities such as scoliosis, dermatology consultation fro skin lesions, workup and followup for vein thrombosis and pulmonary embolism (, intervention for developmental delay, and evaluation for associated neoplasms at regular intervals.<ref name="pmid29166516"></ref><ref name="pmid22876373"></ref><ref name="pmid16883308">{{cite journal |vauthors=Biesecker L |title=The challenges of Proteus syndrome: diagnosis and management |journal=Eur. J. Hum. Genet. |volume=14 |issue=11 |pages=1151–7 |date=November 2006 |pmid=16883308 |doi=10.1038/sj.ejhg.5201638 |url=}}</ref>
* To learn more, click here.
===Bannayan-Riley-Ruvalcaba syndrome===
* An overgrowth syndrome characterized by vascular malformations, macrocephaly, multiple benign neoplasm and pigmented lesions on the skin. Speckled pigmented macules on genitalia are one of the most significant diagnostic characteristics. People with this syndrome may have increased risk of developing neoplasms in many organs such as thyroid, breasts, and female genital tract although it has not been confirmed.<ref name="pmid24474112">{{cite journal |vauthors=Gontijo GM, Pinto CA, Rogatto SR, Cunha IW, Aguiar S, Alves CA |title=Bannayan-Riley-Ruvalcaba syndrome with deforming lipomatous hamartomas in infant--case report |journal=An Bras Dermatol |volume=88 |issue=6 |pages=982–5 |date=2013 |pmid=24474112 |pmc=3900354 |doi=10.1590/abd1806-4841.20132730 |url=}}</ref><ref name="pmid24379037">{{cite journal |vauthors=Peiretti V, Mussa A, Feyles F, Tuli G, Santanera A, Molinatto C, Ferrero GB, Corrias A |title=Thyroid involvement in two patients with Bannayan-Riley-Ruvalcaba syndrome |journal=J Clin Res Pediatr Endocrinol |volume=5 |issue=4 |pages=261–5 |date=2013 |pmid=24379037 |pmc=3890226 |doi=10.4274/Jcrpe.984 |url=}}</ref><ref name="pmid26157835">{{cite journal |vauthors=Sagi SV, Ballard DD, Marks RA, Dunn KR, Kahi CJ |title=Bannayan Ruvalcaba Riley Syndrome |journal=ACG Case Rep J |volume=1 |issue=2 |pages=90–2 |date=January 2014 |pmid=26157835 |pmc=4435287 |doi=10.14309/crj.2014.11 |url=}}</ref>
* Typical manifestations and findings may include  multiple lipomas, hemangiomas, intestinal hamartomatous polyposis, vascular malformations such as arteriovenous malformations and capillary malformations, developmental delay, macrocephaly (>97 percentile), penile pigmented macules, thyroid abnormalities such as multinodular goiter, thyroid adenoma, differentiated non-medullary thyroid cancer and Hashimoto’s thyroiditis, high-arched palate, protuberant frontal bone, hypertelorism, strabismus, macrosomia, hypotonia, joint hyperextensibility, hypoglycemia, convulsions, café-au-lait spots, prominent forehead, malar hypoplasia and  micrognathia.<ref name="pmid24474112"></ref><ref name="pmid24379037"></ref><ref name="pmid11332402">{{cite journal |vauthors=Parisi MA, Dinulos MB, Leppig KA, Sybert VP, Eng C, Hudgins L |title=The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome |journal=J. Med. Genet. |volume=38 |issue=1 |pages=52–8 |date=January 2001 |pmid=11332402 |pmc=1734718 |doi= |url=}}</ref><ref name="pmid10640930">{{cite journal |vauthors=Perriard J, Saurat JH, Harms M |title=An overlap of Cowden's disease and Bannayan-Riley-Ruvalcaba syndrome in the same family |journal=J. Am. Acad. Dermatol. |volume=42 |issue=2 Pt 2 |pages=348–50 |date=February 2000 |pmid=10640930 |doi= |url=}}</ref><ref name="pmid23907246">{{cite journal |vauthors=Bhargava R, Au Yong KJ, Leonard N |title=Bannayan-Riley-Ruvalcaba syndrome: MRI neuroimaging features in a series of 7 patients |journal=AJNR Am J Neuroradiol |volume=35 |issue=2 |pages=402–6 |date=February 2014 |pmid=23907246 |doi=10.3174/ajnr.A3680 |url=}}</ref>
* Mutations in PTEN gene have been thought to be the cause. This gene encodes an enzyme that acts as tumor suppressor by stopping cell division and inducing apoptosis. Both autosomal-dominant transmission and sporadic occurrence have been reported.<ref name="pmid24474112"></ref><ref name="pmid11332402">{{cite journal |vauthors=Parisi MA, Dinulos MB, Leppig KA, Sybert VP, Eng C, Hudgins L |title=The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome |journal=J. Med. Genet. |volume=38 |issue=1 |pages=52–8 |date=January 2001 |pmid=11332402 |pmc=1734718 |doi= |url=}}</ref><ref name="urlPTEN gene - Genetics Home Reference - NIH">{{cite web |url=https://ghr.nlm.nih.gov/gene/PTEN |title=PTEN gene - Genetics Home Reference - NIH |format= |work= |accessdate=}}</ref>
* Diagnosis is based on clinical findings, the most important of these findings being penile pigmented maculae, hamartomatous intestinal polyposis and macrocephaly. Management consists of psycho-social counseling and treatment of manifestations such as surgical and dermatological interventions, spinal stimulation for intractable gastrointestinal pain and screening for malignancies associated with PTEN mutations such as annual thyroid ultrasound and mammography.<ref name="pmid24474112"></ref><ref name="pmid26157835"></ref><ref name="pmid19813502">{{cite journal |vauthors=Yakovlev AE, Resch BE |title=Treatment of intractable abdominal pain patient with Bannayan-Riley-Ruvalcaba syndrome using spinal cord stimulation |journal=WMJ |volume=108 |issue=6 |pages=323–6 |date=September 2009 |pmid=19813502 |doi= |url=}}</ref><ref name="pmid16198785">{{cite journal |vauthors=Erkek E, Hizel S, Sanlý C, Erkek AB, Tombakoglu M, Bozdogan O, Ulkatan S, Akarsu C |title=Clinical and histopathological findings in Bannayan-Riley-Ruvalcaba syndrome |journal=J. Am. Acad. Dermatol. |volume=53 |issue=4 |pages=639–43 |date=October 2005 |pmid=16198785 |doi=10.1016/j.jaad.2005.06.022 |url=}}</ref>
* To learn more, click here.


==References==
==References==
{{reflist|2}}

Latest revision as of 19:30, 22 February 2019

Abbreviations

ACTH: Adrenocorticotropic hormone, ARR: Aldosterone-renin ratio, CAM: Cellular adhesion molecules, ERCP: Endoscopic retrograde cholangiopancreatography, ESR: Erythrocyte sedimentation rate, CT: Computerized tomography, Fluorescence in situ hybridization, FDG: Fluorodeoxyglucose, FSH: Follicle stimulating hormone, GI: Gastrointestinal, H&E stain: Hematoxylin and eosin stain, LCA: Leukocyte common antigen, LDH: Lactate dehydrogenase, LH: Luteinizing hormone, MEN: Multiple endocrine neoplasia, MRCP: Magnetic resonance cholangiopancreatography, MRI: Magnetic resonance imaging, N/A: Not applicable/Not available, N/L: Normal, PAS stain: Periodic acid–Schiff stain, PET: Position emission tomography, PGP: Protein gene product 9.5, TB: Tuberculosis, U/S: Ultrasound, ZF: Zona fasciculata, ZG: Zona granulosa, ZR: Zona reticularis.

Adrenal Cortex Product Clinical manifestations Diagnosis Other features
Symptoms Signs Blood & Urine Histopathological Others Ultrasound CT scan FDG PET/CT MRI
Adrenal Adenoma Aldosterone
[1][2][3][4]
  • Iso and low FDG uptake compared with liver
  • Hyperintense on in-phase and hypointense on oppose-phase
Cortisol
[1][5][6][7]
  • Iso and low FDG uptake compared with liver
  • Hyperintense on in-phase and hypointense on oppose-phase
Androgens
[4][8][9][10]
  • Well-defined
  • Solid mass
  • N/A
  • Hyperintense on in-phase and hypointense on oppose-phase
Non-functional
[1][11][12][13]
  • Solid, well defined mass
  • High lipid content and adjacent compression
  • N/A
  • Hyperintense on in-phase and hypointense on oppose-phase
Adrenal Carcinoma
[12][14][15][16][17]
  • N/A
  • Heterogeneous enhancement
  • Heterogeneous mass with intense FDG uptake greater than liver
  • Heterogenous hyper-intensity (T2-weighted) and hypo-intensity on (T1-weighted)
Adrenal Hyperplasia
[2][5][4][8][9][15][18][19]
  • N/A
  • Unilateral or bilateral adrenal enlargement or thickening
  • Signaling is same as that of normal adrenal gland
Medulla Product Clinical manifestations Diagnosis Other features
Symptoms Signs Blood & Urine Histopathological Others Ultrasound CT scan FDG PET/CT MRI
Pheochromocytoma
[20][21][22][23][24]
  • N/A
Neuroblastoma
[15][25][26][27]
  • Large mass
  • May cross midline
  • N/A
Stains positive for:
Ganglioneuroma
[15][28][29][30]
  • N/A
  • N/A
  • Hypointense (T1-weighted)
  • Varied signal (T2-weighted)

Stains positive for:

Stroma Product Clinical manifestations Diagnosis Other features
Symptoms Signs Blood & Urine Histopathological Others Ultrasound CT scan FDG PET/CT MRI
Lipoma/Myolipoma
[15][31][32][33]
  • N/A
  • N/L
  • N/A
  • High signal
Others Product Clinical manifestations Diagnosis Other features
Symptoms Signs Blood & Urine Histopathological Others Ultrasound CT scan FDG PET/CT MRI
Tuberculosis
[34][35][36][37][38]
  • N/A
  • Variable
Histoplasmosis
[39][40][41][42][43]
  • N/A
Cysts
[15][44][45][46]
  • N/A
  • Gold standard
  • Circumscribed anechoic or hypoechoic mass
  • N/A
  • High signal
Hematoma
[15][47][48][49]
  • N/A
  • Variable
  • N/A
  • Majority of the cases in neonantal peiod
  • Majority of the cases caused by trauma
Hemangioma
[15][50][51][52]
  • N/A
  • Hyperintensity (T2) hypointensity (T1)
  • Peripheral spotty and centripetal enhancement
  • Majority of the cases diagnosed incidentally
  • Majority of the lesions are non-functional with female pre-dominance
Lymphoma
[15][53][54][55]
  • N/A
  • N/A
Cystic Lymphangioma
[15][56][57][58]
  • N/A
  • N/L
  • N/A
  • T1 hypointense & T2 hyperintense
Teratoma
[15][59][60][61]
  • N/A
  • N/L
  • Heterogeneous
  • Mixed echo (U/S)
  • Heterogeneous
  • Mixed density elements
  • Egg-shell calcification
  • Mild enhancement
  • N/A
  • Mild enhancement
  • Mixed signals (MRI)
Metastases
[15][62][63][64][65]
  • Related to the primary tumor
  • N/A
  • Low signal on T1-weighed MRI and high signal on T2-weighed MRI

OR

  • Isointense on T1- and T2-weighed MRI

References

  1. 1.0 1.1 1.2 Park JJ, Park BK, Kim CK (June 2016). "Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses". Br J Radiol. 89 (1062): 20151018. doi:10.1259/bjr.20151018. PMC 5258164. PMID 26867466.
  2. 2.0 2.1 Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P (August 2015). "Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas". Mol. Cell. Endocrinol. 411: 146–54. doi:10.1016/j.mce.2015.04.022. PMC 4474471. PMID 25958045.
  3. Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD (May 2010). "Laboratory investigation of primary aldosteronism". Clin Biochem Rev. 31 (2): 39–56. PMC 2874431. PMID 20498828.
  4. 4.0 4.1 4.2 Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C (2013). "Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging". J Clin Imaging Sci. 3: 61. doi:10.4103/2156-7514.124088. PMC 3935261. PMID 24605256.
  5. 5.0 5.1 Stratakis CA (2008). "Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome)". Endocr Dev. 13: 117–32. doi:10.1159/000134829. PMC 3132884. PMID 18493137.
  6. Zilbermint M, Stratakis CA (June 2015). "Protein kinase A defects and cortisol-producing adrenal tumors". Curr Opin Endocrinol Diabetes Obes. 22 (3): 157–62. doi:10.1097/MED.0000000000000149. PMC 4560837. PMID 25871963.
  7. Wei J, Li S, Liu Q, Zhu Y, Wu N, Tang Y, Li Q, Ren K, Zhang Q, Yu Y, An Z, Chen J, Li J (April 2018). "ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures". BMC Endocr Disord. 18 (1): 22. doi:10.1186/s12902-018-0250-6. PMC 5913873. PMID 29685132.
  8. 8.0 8.1 Arnold DT, Reed JB, Burt K (January 2003). "Evaluation and management of the incidental adrenal mass". Proc (Bayl Univ Med Cent). 16 (1): 7–12. PMC 1200803. PMID 16278716.
  9. 9.0 9.1 Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J (2013). "Pure androgen-secreting adrenal adenoma associated with resistant hypertension". Case Rep Endocrinol. 2013: 356086. doi:10.1155/2013/356086. PMC 3681270. PMID 23819074.
  10. Zhou WB, Chen N, Li CJ (January 2019). "A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman". BMC Endocr Disord. 19 (1): 14. doi:10.1186/s12902-019-0342-y. PMC 6343319. PMID 30674304.
  11. Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A (October 2016). ""Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study". Ann. Intern. Med. 165 (8): 533–542. doi:10.7326/M16-0547. PMC 5453639. PMID 27479926.
  12. 12.0 12.1 Nieman LK (September 2010). "Approach to the patient with an adrenal incidentaloma". J. Clin. Endocrinol. Metab. 95 (9): 4106–13. doi:10.1210/jc.2010-0457. PMC 2936073. PMID 20823463.
  13. Li B, Guo Q, Yang H, Guan J (January 2013). "Giant non-functional adrenal adenoma: A case report". Oncol Lett. 5 (1): 378–380. doi:10.3892/ol.2012.978. PMC 3525484. PMID 23255953.
  14. Libé R (2015). "Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment". Front Cell Dev Biol. 3: 45. doi:10.3389/fcell.2015.00045. PMC 4490795. PMID 26191527.
  15. 15.00 15.01 15.02 15.03 15.04 15.05 15.06 15.07 15.08 15.09 15.10 15.11 Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T (September 2018). "CT and MRI of adrenal gland pathologies". Quant Imaging Med Surg. 8 (8): 853–875. doi:10.21037/qims.2018.09.13. PMC 6177362. PMID 30306064.
  16. Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (April 2014). "Adrenocortical carcinoma". Endocr. Rev. 35 (2): 282–326. doi:10.1210/er.2013-1029. PMC 3963263. PMID 24423978.
  17. Wang C, Sun Y, Wu H, Zhao D, Chen J (March 2014). "Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers". Histopathology. 64 (4): 567–76. doi:10.1111/his.12283. PMC 4282325. PMID 24102952.
  18. Michelle M A, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, Roman-Colon AM, Elsayes KM (November 2017). "Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics". Br J Radiol. 90 (1079): 20170330. doi:10.1259/bjr.20170330. PMC 5963387. PMID 28707538. Vancouver style error: name (help)
  19. Zhang Y, Li H (2015). "Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease". Int J Clin Exp Med. 8 (10): 19311–7. PMC 4694469. PMID 26770569.
  20. Martucci VL, Pacak K (2014). "Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment". Curr Probl Cancer. 38 (1): 7–41. doi:10.1016/j.currproblcancer.2014.01.001. PMC 3992879. PMID 24636754.
  21. Kantorovich V, Pacak K (2010). "Pheochromocytoma and paraganglioma". Prog. Brain Res. 182: 343–73. doi:10.1016/S0079-6123(10)82015-1. PMC 4714594. PMID 20541673.
  22. Miller AD, Masek-Hammerman K, Dalecki K, Mansfield KG, Westmoreland SV (November 2009). "Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus)". Vet. Pathol. 46 (6): 1221–9. doi:10.1354/vp.09-VP-0022-M-FL. PMID 19605896.
  23. Kantorovich V, Eisenhofer G, Pacak K (December 2008). "Pheochromocytoma: an endocrine stress mimicking disorder". Ann. N. Y. Acad. Sci. 1148: 462–8. doi:10.1196/annals.1410.081. PMC 2693284. PMID 19120142.
  24. Eisenhofer G, Peitzsch M (December 2014). "Laboratory evaluation of pheochromocytoma and paraganglioma". Clin. Chem. 60 (12): 1486–99. doi:10.1373/clinchem.2014.224832. PMID 25332315.
  25. Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG (October 2014). "Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project". J. Clin. Oncol. 32 (28): 3169–76. doi:10.1200/JCO.2014.56.1621. PMC 4171360. PMID 25154816.
  26. Bordbar M, Tasbihi M, Kamfiroozi R, Haghpanah S (2014). "Epidemiological and clinical characteristics of neuroblastoma in southern iran". Iran J Ped Hematol Oncol. 4 (3): 89–96. PMC 4173027. PMID 25254086.
  27. Skoura E, Oikonomopoulos G, Vasileiou S, Kyprianou D, Koumakis G, Datseris IE (2014). "(18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma". Hell J Nucl Med. 17 (1): 58–61. doi:10.1967/s002449910116. PMID 24563879.
  28. Mylonas KS, Schizas D, Economopoulos KP (October 2017). "Adrenal ganglioneuroma: What you need to know". World J Clin Cases. 5 (10): 373–377. doi:10.12998/wjcc.v5.i10.373. PMC 5648998. PMID 29085827.
  29. Adas M, Koc B, Adas G, Ozulker F, Aydin T (April 2014). "Ganglioneuroma presenting as an adrenal incidentaloma: a case report". J Med Case Rep. 8: 131. doi:10.1186/1752-1947-8-131. PMC 4031973. PMID 24779851.
  30. Li J, Yang CH, Li LM (April 2013). "Diagnosis and treatment of 29 cases of adrenal ganglioneuroma". Eur Rev Med Pharmacol Sci. 17 (8): 1110–3. PMID 23661526.
  31. Lam KY, Lo CY (September 2001). "Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution". J. Clin. Pathol. 54 (9): 707–12. PMC 1731508. PMID 11533079.
  32. Gershuni VM, Bittner JG, Moley JF, Brunt LM (January 2014). "Adrenal myelolipoma: operative indications and outcomes". J Laparoendosc Adv Surg Tech A. 24 (1): 8–12. doi:10.1089/lap.2013.0411. PMC 3931430. PMID 24328509.
  33. Luo J, Chen L, Wen Q, Xu L, Chu S, Wang W, Alnemah MM, Fan S (2015). "Lipoadenoma of the adrenal gland: report of a rare entity and review of literature". Int J Clin Exp Pathol. 8 (8): 9693–7. PMC 4583971. PMID 26464739.
  34. Rodríguez-Gutiérrez R, Rendon A, Barrera-Sánchez M, Carlos-Reyna KE, Álvarez-Villalobos NA, González-Saldivar G, González-González JG (2016). "Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test". Int J Endocrinol. 2016: 9051865. doi:10.1155/2016/9051865. PMC 4781954. PMID 27006656.
  35. Haddara WM, van Uum SH (September 2004). "TB and adrenal insufficiency". CMAJ. 171 (7): 710, author reply 710–1. doi:10.1503/cmaj.1041046. PMC 517840. PMID 15451821.
  36. Huang YC, Tang YL, Zhang XM, Zeng NL, Li R, Chen TW (October 2015). "Evaluation of primary adrenal insufficiency secondary to tuberculous adrenalitis with computed tomography and magnetic resonance imaging: Current status". World J Radiol. 7 (10): 336–42. doi:10.4329/wjr.v7.i10.336. PMC 4620114. PMID 26516430.
  37. Vinnard C, Blumberg EA (January 2017). "Endocrine and Metabolic Aspects of Tuberculosis". Microbiol Spectr. 5 (1). doi:10.1128/microbiolspec.TNMI7-0035-2016. PMID 28233510.
  38. Rajasekharan C, Ajithkumar S, Anto V, Parvathy R (May 2013). "Extrapulmonary disseminated tuberculosis with tuberculous adrenalitis: a stitch in time saves nine". BMJ Case Rep. 2013. doi:10.1136/bcr-2012-008011. PMID 23687365.
  39. Rog CJ, Rosen DG, Gannon FH (December 2016). "Bilateral adrenal histoplasmosis in an immunocompetent man from Texas". Med Mycol Case Rep. 14: 4–7. doi:10.1016/j.mmcr.2016.11.006. PMC 5154969. PMID 27995051.
  40. Wahab NA, Mohd R, Zainudin S, Kamaruddin NA (2013). "Adrenal involvement in histoplasmosis". EXCLI J. 12: 1–4. PMC 4817423. PMID 27047312.
  41. May D, Khaled D, Gills J (July 2018). "Unilateral adrenal histoplasmosis". Urol Case Rep. 19: 54–56. doi:10.1016/j.eucr.2018.03.010. PMC 5991316. PMID 29888193.
  42. Gupta RK, Majumdar K, Srivastava S, Varakanahalli S, Saran RK (2018). "Endoscopic Ultrasound-guided Cytodiagnosis of Adrenal Histoplasmosis with Reversible CD4 T-Lymphocytopenia and Jejunal Lymphangiectasia". J Cytol. 35 (2): 110–113. doi:10.4103/JOC.JOC_234_15. PMC 5885598. PMID 29643659.
  43. Padma S, Sreehar S (May 2014). "18F FDG PET/CT identifies unsuspected bilateral adrenal histoplasmosis in an elderly immuno compromised patient". Indian J. Med. Res. 139 (5): 786–7. PMC 4140048. PMID 25027093.
  44. Carsote M, Ghemigian A, Terzea D, Gheorghisan-Galateanu AA, Valea A (2017). "Cystic adrenal lesions: focus on pediatric population (a review)". Clujul Med. 90 (1): 5–12. doi:10.15386/cjmed-677. PMID 28246490.
  45. Słapa RZ, Jakubowski WS, Dobruch-Sobczak K, Kasperlik-Załuska AA (December 2015). "Standards of ultrasound imaging of the adrenal glands". J Ultrason. 15 (63): 377–87. doi:10.15557/JoU.2015.0035. PMC 4710689. PMID 26807295.
  46. Olaoye IO, Adesina MD, Afolayan EA (June 2018). "A giant adrenal cyst with an uncertain preoperative diagnosis causing a dilemma in management". Clin Case Rep. 6 (6): 1074–1076. doi:10.1002/ccr3.1519. PMC 5986023. PMID 29881567.
  47. Hamilton D, Harris MD, Foweraker J, Gresham GA (February 2004). "Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection". J. Clin. Pathol. 57 (2): 208–9. PMC 1770213. PMID 14747454.
  48. Di Serafino M, Severino R, Coppola V, Gioioso M, Rocca R, Lisanti F, Scarano E (September 2017). "Nontraumatic adrenal hemorrhage: the adrenal stress". Radiol Case Rep. 12 (3): 483–487. doi:10.1016/j.radcr.2017.03.020. PMC 5551907. PMID 28828107.
  49. Ierardi AM, Petrillo M, Patella F, Biondetti P, Fumarola EM, Angileri SA, Pesapane F, Pinto A, Dionigi G, Carrafiello G (April 2018). "Interventional radiology of the adrenal glands: current status". Gland Surg. 7 (2): 147–165. doi:10.21037/gs.2018.01.04. PMC 5938278. PMID 29770310.
  50. Alhajri K, Alhasan I, Alzerwi N, Abudaff N (April 2011). "Adrenal haemangioma". BMJ Case Rep. 2011. doi:10.1136/bcr.12.2010.3604. PMC 3079485. PMID 22701011.
  51. Iwamoto G, Shimokihara K, Kawahara T, Takamoto D, Yao M, Teranishi JI, Otani M, Uemura H (2018). "Adrenal Hemangioma: A Case of Retroperitoneal Tumor". Case Rep Med. 2018: 8796327. doi:10.1155/2018/8796327. PMC 5836307. PMID 29560018.
  52. Tarchouli M, Boudhas A, Ratbi MB, Essarghini M, Njoumi N, Sair K, Zentar A (2015). "Giant adrenal hemangioma: Unusual cause of huge abdominal mass". Can Urol Assoc J. 9 (11–12): E834–6. doi:10.5489/cuaj.2967. PMC 4639440. PMID 26600897.
  53. Harada K, Kimura K, Iwamuro M, Terasaka T, Hanayama Y, Kondo E, Hayashi E, Yoshino T, Otsuka F (September 2017). "The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency". Intern. Med. 56 (17): 2261–2269. doi:10.2169/internalmedicine.8216-16. PMC 5635296. PMID 28794358.
  54. Laurent C, Casasnovas O, Martin L, Chauchet A, Ghesquieres H, Aussedat G, Fornecker LM, Bologna S, Borot S, Laurent K, Bouillet B, Verges B, Petit JM (February 2017). "Adrenal lymphoma: presentation, management and prognosis". QJM. 110 (2): 103–109. doi:10.1093/qjmed/hcw174. PMID 27795295.
  55. Karimi F (October 2017). "Primary Adrenal Lymphoma Presenting with Adrenal Failure: A Case Report and Review of the Literature". Int J Endocrinol Metab. 15 (4): e12014. doi:10.5812/ijem.12014. PMC 5750783. PMID 29344029.
  56. Michalopoulos N, Laskou S, Karayannopoulou G, Pavlidis L, Kanellos I (December 2015). "Adrenal Gland Lymphangiomas". Indian J Surg. 77 (Suppl 3): 1334–42. doi:10.1007/s12262-015-1206-y. PMC 4775622. PMID 27011561.
  57. Zhao M, Gu Q, Li C, Yu J, Qi H (2014). "Cystic lymphangioma of adrenal gland: a clinicopathological study of 3 cases and review of literature". Int J Clin Exp Pathol. 7 (8): 5051–6. PMC 4152068. PMID 25197378.
  58. Joliat GR, Melloul E, Djafarrian R, Schmidt S, Fontanella S, Yan P, Demartines N, Halkic N (February 2015). "Cystic lymphangioma of the adrenal gland: report of a case and review of the literature". World J Surg Oncol. 13: 58. doi:10.1186/s12957-015-0490-0. PMC 4335415. PMID 25889625.
  59. Ramakant P, Rana C, Singh KR, Mishra A (2018). "Primary adrenal teratoma: An unusual tumor - Challenges in diagnosis and surgical management". J Postgrad Med. 64 (2): 112–114. doi:10.4103/jpgm.JPGM_588_16. PMC 5954807. PMID 29067922.
  60. Li S, Li H, Ji Z, Yan W, Zhang Y (November 2015). "Primary adrenal teratoma: Clinical characteristics and retroperitoneal laparoscopic resection in five adults". Oncol Lett. 10 (5): 2865–2870. doi:10.3892/ol.2015.3701. PMC 4665718. PMID 26722254.
  61. Zhou L, Pan X, He T, Lai Y, Li W, Hu Y, Ni L, Yang S, Chen Y, Lai Y (October 2018). "Primary adrenal teratoma: A case series and review of the literature". Mol Clin Oncol. 9 (4): 437–442. doi:10.3892/mco.2018.1687. PMC 6125700. PMID 30214733.
  62. Karanikiotis C, Tentes AA, Markakidis S, Vafiadis K (November 2004). "Large bilateral adrenal metastases in non-small cell lung cancer". World J Surg Oncol. 2: 37. doi:10.1186/1477-7819-2-37. PMC 535544. PMID 15541184.
  63. ABRAMS HL, SPIRO R, GOLDSTEIN N (January 1950). "Metastases in carcinoma; analysis of 1000 autopsied cases". Cancer. 3 (1): 74–85. PMID 15405683.
  64. Gerber E, Dinlenc C, Wagner JR (2004). "Laparoscopic adrenalectomy for isolated adrenal metastasis". JSLS. 8 (4): 314–9. PMC 3016821. PMID 15554272.
  65. Vaughan ED (September 1998). "Diagnosis and management of surgical adrenal disorders". Int. J. Urol. 5 (5): 401–17. PMID 9781426.